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Abstract: Spironucleosides are a type of conformationally restricted nucleoside analogs in which
the anomeric carbon belongs simultaneously to the sugar moiety and to the base unit. This locks
the nucleic base in a specific orientation around the N-glycosidic bond, imposing restrictions on the
flexibility of the sugar moiety. Anomeric spiro-functionalized nucleosides have gained considerable
importance with the discovery of hydantocidin, a natural spironucleoside isolated from fermentation
broths of Streptomyces hygroscopicus which exhibits potent herbicidal activity. The biological activity of
hydantocidin has prompted considerable synthetic interest in this nucleoside and also in a variety of
analogues, since important pharmaceutical leads can be found among modified nucleoside analogues.
We present here an overview of the most important advances in the synthesis of spironucleosides.
Keywords: spironucleosides; spirohydantoins; spirodiketopiperazines; sugar amino acids
1. Introduction
The study of the chemistry and biochemistry of nucleosides has been a fundamental research field
since the crucial role of nucleic acids in cells was established in the 1950s. It was then when the role of
nucleic acids as constituents of the macromolecules that convey genetic information in living cells was
established. As the metabolic processes involving nucleic acids became understood, the interest in
analogues nucleosides grew. In this regard, nucleoside analogues has been a subject of great interest in
the development of novel drugs owing to the fact that they can be involved in the disruption of nucleic
acid biosynthesis and thus inhibit a series of crucial biological processes, such as cellular division
and viral replication [1]. Using this concept, several nucleoside analogues designed to interact with
DNA (RNA) and to inhibit enzymes utilizing them possess antiviral, antimetabolic, and antibacterial
properties and are currently in use in clinical fields [2–11].
The extensive search for clinically useful nucleoside derivatives has resulted in a plethora of
bioactive modified nucleosides. Taking into account that in many occasions there is a close correlation
between reduced conformational flexibility and a potent interaction with biomacromolecules,
the modifications include the preparation of conformationally restricted nucleosides. These nucleoside
analogues can show a dramatic improvement in enzymatic recognition, as well as enhancing
base stacking and backbone pre-organization [12]. Conformational restriction of the furanose ring
of nucleosides, nucleotides and oligonucleotides has been intensively pursued in recent years,
stimulated by the potential application of these molecules as therapeutic agents [13–16]. Among those,
spiro-functionalized nucleosides have recently gained more interest.
Spironucleosides are a family of conformationally restricted nucleosides in which the anomeric
carbon belongs simultaneously to a pyranoid or furanoid sugar ring and to an aza-heterocyclic
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moiety [17]. This fixes the nucleotide base in a specific orientation around the N-glycosidic
bond, thus altering the flexibility of the sugar moiety. Anomeric spirocyclic nucleosides gained
considerable interest with the discovery of (+)-hydantocidin, a natural spironucleoside isolated from
fermentation broths of Streptomyces hygroscopicus SANK 63584 [18,19], Tu-2474 [20] and A1491 [21].
Hydantocidin exhibits potent herbicidal and plant growth regulatory activity with high selective
toxicity between plants and animals [22] Biochemical studies have shown that hydantocidin is
a proherbicide which is phosphorylated at the 5′ position in vivo and inhibits adenylosuccinate
synthetase (AdSS) [23], an enzyme that plays an important role in the de novo purine synthesis in
plants [24]. These observations have understandably stimulated considerable interest, not only in
the synthesis of (+)-hydantocidin itself, but also in a variety of its analogues, with the notion that
important pharmaceutical leads can be found among modified nucleoside analogues. A number of
anomeric spirocyclic nucleosides have subsequently appeared in the literature being hydantoines or
diketopiperazines analogues, but also, barbiturates and more diverse spiroheterocyclic subunits.
This extensive research on the synthesis and biology of hydantocidin analogues was awarded
with the discovery of a glucopyranose spirohydantoin which is the most active inhibitor of glycogen
phosphorylase (GP) known to date, with a Ki value of 3.1 µM [25]. Glycogen phosphorylase is a key
enzyme in the regulation of muscle and hepatic glycogen metabolism, and catalyzes the first step in
the intracellular degradation of glycogen [26–29]. Inhibition of glycogen phosphorylase is believed to
assist in shifting the equilibrium between glycogen degradation and glycogen synthesis in favor of
the latter in both muscle and liver [30–33]. Therefore, GP inhibitors may be clinically useful for the
treatment of diabetes mellitus, especially the non-insulin dependent diabetes mellitus (NIDDM or
type II diabetes) [34,35].
Most of the synthetic strategies for spironucleosides revolve around the use of carbohydrate
derivatives to generate the desired stereochemistry in the sugar ring. However, a very diverse range of
strategies are available for the synthesis of the characteristic spirocyclic base. Unfortunately, to the best
of our knowledge, the literature suffers from the lack of an exhaustive review on the preparation of
spironucleosides. Our main aim in this review is to draw together all of the synthetic information on
spironucleosides in a form which is easily consulted The coverage is primarily from the point of view
of organic chemists, so our intention is to describe in detail those strategies that have been employed
to synthetize spiroonucleosides.
2. Synthesis of Hydantoins
2.1. (+)-Hydantocidin
The most representative member of the hydantoins family is (+)-hydantocidin (1, Figure 1),
a natural spironucleoside displaying potent herbicidal activity with high selective toxicity between
plants and animals.
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Figure 1. Natural spironucleoside (+)-hydantocidin (1). 
This interesting biological profile prompted many research groups to investigate the synthesis 
of hydantocidin (1). The first total synthesis of 1, proposed by Mio and co-workers in 1991, included 
as key step the condensation of a tetrose and a hydantoin ring [36]. Starting from 4-O-benzyl-2,3-
This interesting biological profile prompted many research groups to investigate the synthesis
of hydantocidin (1). The first total synthesis of 1, proposed by Mio and co-workers in 1991, included
as key step the condensation of a tetrose and a hydantoin ring [36]. Starting from 4-O-benzyl-2,3-
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isopropylidene-D-threose (3), aldol condensation with l-N-acetyl-3-N-(4-methoxybenzyl)hydantoin (2)
in the presence of potassium tert-butoxide afforded a mixture of (Z)-isomer 4 and (E)-isomer 5
(Scheme 1). Treatment of both isomers 4 and 5 under transketalization conditions led to the mixture
of cyclized products 6 and 7, which were separated by column chromatography. Introduction
of a benzyloxycarbonyl group at the amide-NH group of 6, followed by diastereoselective
dihydroxylation of the olefin on the β-face and removal of the protecting groups, finally gave desired
(+)-hydantocidin (1).
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Scheme 1. Mio et al. total synthesis of (+)-hydantocidin (1). Reagents and conditions: (i) t-BuOK, 
dioxane, r.t., 4 h, 71% of 4 and 14% of 5; (ii) p-TsOH-H2O, MS 4Å, reflux, 2 h, 82%, 6/7 63:37; (iii) CbzCl, 
t-BuOK, THF, r.t.; (iv) OsO4, N-methylmorpholine-N-oxide, acetone/H2O, r.t., 24 h, 48%; (v) CAN, 
CH3CN/H2O, r.t., 20 min, 94%; (vi) H2/Pd-C (5%), CH3OH, 55 °C, 6 h. 
Because of the need for laborious chromatography, this methodology is inconvenient for the 
large-scale synthesis of (+)-hydantocidin. Mio and co-workers subsequently developed a new 
synthetic method overcoming these problems [37]. The procedure (Scheme 2) involves the N-
glycosidation of a D-psicofuranose derivative prior to the formation of the hydantoin ring. Thus, 
treatment of psicofuranose derivative 10 [38] with azidotrimethylsilane in the presence of catalytic 
amounts of trimethylsilyltriflate, afforded the desired azide 11. Oxidation of the primary hydroxyl 
group to the corresponding carboxylic acid, followed by coupling with ammonia, afforded amide 12. 
Reaction of 12 with tributylphosphine in acetonitrile yielded the corresponding spiro-hydantoin, 
which was immediately acetylated in order to avoid epimerization at the spiro-center to afford 13. 
Removal of the protecting groups finally gave desired hydantocidin (1). 
Since the isomer bearing the nitrogen in the α-anomeric position is thermodynamically more 
stable than the desired β-isomer, the main challenge in the synthesis of hydantocidin is the control of 
the anomeric configuration. In an attempt to overcome this limitation, Chemla described an 
alternative synthesis of hydantocidin from protected psicofuranose 15 using as key step an oxygen-
bridged intramolecular Vorbrüggen coupling of an intermediate N-hydroxyurea [39]. Initially, 15 
was converted into the p-methoxybenzylurea 16, which on treatment with a catalytic amount of 
trimethylsilyltriflate led to the isoxazolidine 17 (Scheme 3). 
. i t l. t t l s t sis f ( )- t i i ( ). ts iti s: (i) t- ,
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Because of the need for laborious chromatography, this methodology is inconvenient for the
large-scale synthesis of (+)-hydantocidin. Mio and co-workers subsequently developed a new synthetic
method overcoming these problems [37]. The procedure (Scheme 2) involves the N-glycosidation
of a D-psicofuranose derivative prior to the formation of the hydantoin ring. Thus, treatment of
psicofuranose derivative 10 [38] with azidotrimethylsilane in the presence of catalytic amounts of
trimethylsilyltriflate, afforded the desired azide 11. Oxidation of the primary hydroxyl group to the
corresponding carboxylic acid, followed by coupling with ammonia, afforded amide 12. Reaction
of 12 with tributylphosphine in acetonitrile yielded the corresponding spiro-hydantoin, which was
immediately acetylated in order to avoid epimerization at the spiro-center to afford 13. Removal of the
protecting groups finally gave desired hydantocidin (1).
Since the isomer bearing the nitrogen in the α-anomeric position is thermodynamically more
stable than the desired β-isomer, the main challenge in the synthesis of hydantocidin is the control of
the anomeric configuration. In an attempt to overcome this limitation, Chemla described an alternative
synthesis of hydantocidin from protected psicofuranose 15 using as key step an oxygen-bridged
intramolecular Vorbrüggen coupling of an intermediate N-hydroxyurea [39]. Initially, 15 was converted
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into the p-methoxybenzylurea 16, which on treatment with a catalytic amount of trimethylsilyltriflate
led to the isoxazolidine 17 (Scheme 3).Molecules 2017, 22, 2028 4 of 35 
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After oxidation of the free hydroxy group in 17 to the corresponding carboxylic acid and removal 
of the PMB protecting group, subsequent cyclization to the tricyclic isoxazolidine hydantocidin 18, 
followed acidic hydrolysis finally afforded desired (+)-hydantocidin (1). 
In spite of the considerable synthetic work focused to the synthesis of hydantocidin, the problem 
of accessing multigram quantities remained unresolved. In 2002, Shiozaki reported a synthesis of 
hydantocidin from dichloroolefin 20, easily available from protected D-ribonolactone 19 (Scheme 4) [40]. 
Oxidation of 20 with MCPBA afforded a 4:1 anomeric mixture of chlorosugars 21 and 22. Conversion 
of 21 to urea 24 was easily accomplished via azide 23. Finally, formation of the hydantoin ring, 
followed by hydrogenolysis and acidic hydrolysis yielded hyantocidin (1). 
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(vi) 1. NH2NH2, MeOH, r.t.; 2. H2, Pd/C, MeOH, 55 ◦C, 30 min, 88%.
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After oxidation of the free hydroxy group in 17 to the corresponding carboxylic acid and removal
of the PMB protecting group, subsequent cyclization to the tricyclic isoxazolidine hydantocidin 18,
followed acidic hydrolysis finally afforded desired (+)-hydantocidin (1).
In spite of the considerable synthetic work focused to the synthesis of hydantocidin, the problem
of accessing multigram quantities remained unresolved. In 2002, Shiozaki reported a synthesis of
hydantocidin from dichloroolefin 20, easily available from protected D-ribonolactone 19 (Scheme 4) [40].
Oxidation of 20 with MCPBA afforded a 4:1 anomeric mixture of chlorosugars 21 and 22. Conversion of 21
to urea 24 was easily accomplished via azide 23. Finally, formation of the hydantoin ring, followed by
hydrogenolysis and acidic hydrolysis yielded hyantocidin (1).
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Once accomplished the synthesis of the natural product itself, Mio and co-workers reported the
preparation of all the stereoisomers of hydantocidin [41]. For example, starting from the substituted
hydantoin 35 an aldol condensation with tetrose L-36 afforded condensate 37 as a mixture of four
diastereomers (Scheme 5).
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Scheme 5. Mio and co-workers’ preparation of the diastereoisomers of (+)-hydantocidin (1). Reagents 
and conditions: (i) LiN(TMS)2, THF, −20 °C, 2 h, 76%; (ii) t-BuOK, MeOCOCl, THF, 0 °C, 30 min; (iii) 
aq K2CO3, MeOH, r.t., 1.5 h; (iv) p-TsOH, ethylene glycol, dichloroethane, 60 °C, from 37a: 71% of 38 
and 14% of 39; from 37c: 74% of 38 and 15% of 39; (v) 1. TBAF, THF, 0 °C, 15 min, 78–85%; 2. CAN, 
2:1 MeCN/water, r.t., 20 min, 78–86%; 3. H2, Pd/C, EtOAc, 24 °C, 30 min, 61–81%. 
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(iii) aq K2CO3, MeOH, r.t., 1.5 h; (iv) p-TsOH, thylene glycol, dichloroethane, 60 ◦C, from 37a: 71%
of 38 and 14% of 39; from 37c: 74% of 38 and 15% of 39; (v) 1. TBAF, THF, 0 ◦C, 15 min, 78–85%;
. CAN, 2:1 MeCN/water, r.t., 20 min, 78–86%; 3. H2, Pd/C, EtOAc, 24 ◦C, 30 min, 61–81%.
After chromatographic separation, isomers 37a and 37c were transformed into the same pair of
two cyclized isomers 38 and 39, which after removal of the protecting groups provided isomers 25
and 26. Similarly, isomers 37b and 37d provided the other two isomers of the L-series, compounds 27
and 28. In addition, when the same sequence of reactions was applied to aldehyde D-36, the four
isomers of the D-series were obtained.
Based on the diastereoselective dihydroxylation of spiro-2,5-dihydrofuran systems, Mio and
co-workers also reported a general synthetic route for the diastereoisomers of the series of D-sugars [42].
In this methodology, the selectivity is controlled by the choice of substituents at N-6 position (H or Cbz).
Thus, catalytic osmium tetroxide oxidation of spiro-2,5-dihydrofurane 7 afforded a single isomer 41,
while oxidation of the N-benzyloxycarbonyl protected derivative 40 gave isomer 42 (Scheme 6).
The cis-isomers 41 and 42 were then easily converted to hydantocidin stereoisomers 29 and 33.
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Scheme 6. Mio et al. general synthetic route to the D-sugar diastereoisomer series. Reagents
and conditions: (i) OsO4, N-methylmorpholine-N-oxide, acetone/H2O, r.t., 6 h, 76%; (ii) OsO4,
N-methylmorpholine-N-oxide, acetone/H2O, 35 ◦C, 67 h, 53%; (iii) 1. CAN, 2:1 MeCN/H2O, r.t.,
15 min, 50%; 2. H2, Pd/C, EtOAc, 55 ◦C, 6 h, 66%.
For the synthesis of the trans isomers, the strategy involves the opening of the corresponding
3,4-epoxid s in an acidic medium (Scheme 7). Epoxidation of 7 with m-chlorop benzoic cid, followed
by a idic ring-op ning gav dihydr xy compo nds 43 and 44, as the rather drastic acidic conditions
used fo the epoxide opening resulted in the epimerization at the anomeric position. Interestingly,
the ring opening occurred selectively on the C-3 position, although the factor involved in this
regioselectivity are unknown. Removal of the protecting groups finally afforded the desired trans
isomers 31 and 32.
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dichloroethane, reflux, 4 h, 41%; (ii) 50% aq. H2SO4, DME, 50 ◦C, 7 h, 17% of 43 and 30% of 44;
(iii) 1. CAN, MeCN/H2O (2:1), r.t.; 2. H2, Pd/C, EtOAc, 55 ◦C, 21% of 31 and 27% of 32.
Fleet et al. report d a short synthesis of 5-epi-hydantocidin 29 from a D-ribose-derived
azidolactone [43]. Oxidation of azidonolactone 45 [44] with tetra-n-propyla monium perruthenate
(TPAP) in the presence of morpholine-N-oxide gave a single product 46 (Scheme 8).
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Scheme 8. Fleet et al. short synthesis of 5-epi-hydantocidin (29). Reagents and conditions: (i) TPAP,
morpholine-N-oxide, MeCN, r.t., 1 h, 60%; (ii) KOCN, AcOH, 60 ◦C, 1.5 h, 76%; (iii) 1. tert-BuOK, THF,
r.t. 10 min, 61%; 2. aq. CF3COOH, r.t., 2 h, 98%.
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Treatment of 46 with potassium cyanate in acetic acid afforded the corresponding urea, which on
reaction with potassium tert-butoxide and acidic hydrolysis gave epihydantocidin 29.
In order to gain further insight into the role of the hydroxyl groups in the structure-herbicidal
activity, a number of deoxy-derivatives of hydantocidin were also prepared (Figure 3).
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Scheme 10. Synthesis of deoxyhydantocin 51. Reagents and conditions: (i) H2, Pd/C, EtOAc, 55 °C, 
78%; (ii) (PhO)3P+I−, DMF, r.t., 2 h, 90%; (iii) n-Bu3SnH, AIBN, toluene, r.t., 85%; (iv) 1. Dowex 50W 
(H+), MeOH/H2O, 70 °C, 1 h, 85%; 2. NH2NH2, MeOH, r.t., 30 min, 70%. 
Even though the mode of herbicidal action of hydantocidin remained elusive at that time, Fleet 
and co-workers surmised that spirohydantoins of other sugars could also possess other interesting 
biological properties, so they initiated extensive investigations targeting diverse hydantoins of 
pentoses other than ribose and hexoses (Figure 4). 
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Starting from spiro-hydantoin derivative 6, deprotection of the p-methoxybenzyl group followed
by hydrogenation afforded dideoxy derivative 48 (Scheme 9) [45]. Mono-deoxyisomers 49 and 50 were
synthesized from common intermediate 52, which was derived from 8 via thiocarbonylation, radical
reduction and deprotection.
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Even though the mode of herbicidal action of hydantocidin remained elusive at that time, Fleet 
and co-workers surmised that spirohydantoins of other sugars could also possess other interesting 
biological properties, so they initiated extensive investigations targeting diverse hydantoins of 
pentoses other than ribose and hexoses (Figure 4). 
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r.t., 7 min, 86%; (ii) H2, Pd/C, EtOAc, 55 ◦C, 5 h, 65%; (iii) (imd)2CS, toluene, 100 ◦C, 1 h, 69%;
(iv) 1. n-Bu3SnH, AIBN, toluene, r.t., 39% of 53 and 30% of 54; (v) CAN, MeC /H2O (2:1), r.t.; (vi) H2,
Pd/C, EtOAc, 55 ◦C, 75% of 49 and 80% of 5 .
For the synthesis of deoxy-hydantocin 51, compound 55 was chosen as starting material
(Scheme 10). Debenzylation and iodination of the resulting hydroxy derivative yielded
iodo-hydantocidin 56. Removal of the iodine under radical conditions, followed by acidic hydrolysis
of the isopropylidene protecting group finally afforded deoxy-hydantocidin 51.
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Even though the mode of herbicidal action of hydantocidin remained elusive at that time, Fleet 
and co-workers surmised that spirohydantoins of other sugars could also possess other interesting 
biological properties, so they initiated extensive investigations targeting diverse hydantoins of 
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Even though the mode of herbicidal action of hydantocidin remained elusive at that time,
Fleet and co-workers surmised that spirohydantoins of other sugars could also possess other interesting
biological properties, so they initiated extensive investigations targeting diverse hydantoins of pentoses
other than ribose and hexoses (Figure 4).Molecules 2017, 22, 2028 9 of 35 
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i re 4. a t i s f e t ses a ex ses.
For example, Fleet’s group reported the first example of hexose-derived hydantoins, in a synthetic
sequence using as key step an oxidative ring contraction of an α-amino-δ-lactone [46]. Hydrogenation
of the azidolactone 61 gave the corresponding amine, which on oxidation with bromine in methanol
in the presence of sodium acetate, followed by addition of triethylamine gave the amine ester 62 as
the major product (Scheme 11). Reaction of 62 with phenyl isocyanate afforded the urea 63, which on
standing in methanol, spontaneously cyclised to the fully protected hydantoin 64. Acidic hydrolysis of
64 gave the unprotected phenylhydantoin 57.
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Sche e 11. exose-derived hydantoin synthesis. Reagents and conditions: (i) 2, Pd black, Et c,
r.t., 60 ; (ii) Br2, NaOAc, MeOH then Et3N (iii) PhNCO, THF, r.t.; (iv) MeOH; (v) 1. 80% aq. AcOH, r.t.
2. 40% aq. CF3CO2H, r.t., 96%.
For the synthesis of glucose-derived hydantoins, readily available glucoheptonolactone was used
as s ar ing material [47]. Ring contraction of gluco eptonolacton deriva ive 65, followed by prot ction
of the diol with tert-butyldimethylsilyl chloride, afforded the tetrahydrofuran 66 (Scheme 12).
Radical bromination and subsequent reaction of the resulting bromides with sodium azide gave, after
hydrogenation and reaction with phenyl isocyanate, ureas 67 and 68. Potassium tert-butoxide-promoted
cyclisation, followed by acidic hydrolysis, finally gave anomeric spirohydantoins 58 and 59.
As yet another contribution of Fleet’s group to the chemistry of sugar hydantoins, in 2006 these
researchers reported the synthesis of lyxofuranose analogues of hydantocidin [48]. L-Fucose-derived
triflate 69 [49] was transformed into inseparable mixture of epimeric azidoesters 72 (Scheme 13).
From this mixture, lyxofuranose hydantoin 60 was obtained using the methodology established in
the group for the construction of a spirohydantoin ring (formation and subsequent cyclization of
an intermediate urea).
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Scheme 12. Glucose-derived hydantoin synthesis. Reagents and conditions: (i) 1. (CF3SO2)2O, Py,
CH2Cl2, 77%; 2. H+, Me2CO, r.t., 80%; 3. Me2tBuSiCl, imidazole, DMF, 65 ◦C, 80%; (ii) 1. NBS,
(PhCOO)2, CCl4, 80 ◦C; 2. NaN3, DMF, r.t., 37% and 34%; 3. H2, Pd, MeOH, r.t.; 4. PhNCO, THF, r.t.,
36% of 67 and 63% of 68; (iii) 1. tert-BuOK, DMF, 88% and 78%; 2. CF3COOH, dioxane, H2O, 73% of 58
and 75% of 59.
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synthesis of the spirohydantoins of glucopyranose from the methyl ester 77 [50]. Treatment of 77 [51] with 
lithium bis(trimethylsilyl)amide and carbon tetrabromide gave an intermediate bromide, which was 
transformed into the ureas 79 and 80 via intermediate amines 78 (Scheme 14). Unlike in the case of 
the ribofuranosyl hydantoins, once the nitrogen of the quaternary anomeric centre has been acylated, 
there is no longer a kinetically easy pathway for the equilibration of the anomers to take place and 79 
and 80 were separated by flash chromatography. Reaction of 79 with potassium tert-butoxide 
afforded, after removal of the protecting groups, glucopyranosyl hydantoin 73. Following the same 
synthetic sequence, hydantoin 74 was obtained from 80. As predicted by the molecular modeling 
Scheme 13. Fleet et al. synthesis of epimeric azidoesters. Reagents and conditions: (i) CF3COONa,
DMF; (ii) Tf2O, pyridine,−30 ◦C, 84%; (iii) 1. 3% HCl in MeOH; 2. 2,2-dimethoxypropane, CSA, acetone,
97%; (iv) 1. NBS, CCl4, (PhCOO)2; 2. NaN3, DMF, r.t., 74%; (v) 1. H2, Pd/C, MeOH, 70%; 2. KOCN,
AcOH, 74%; 3. 50% aq TFA, 94%.
2.2.2. Pyranoses
As stated in the introduction, Fleet and co-workers discovered a glucopyranose spirohydantoin
which is the most active inhibitor of glycogen phosphorylase (GP) and therefore may be clinically
useful for the treatment of diabetes mellitus. Inspired by the biological relevance of the glucopyranose
hydantocidin, several pyranose analogues of hydantocidin were synthetized (Figure 5).
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Figure 5. Pyranose derivatives of hydantocidin.
Before pyranose analogues of hydantocidin were described, molecular modelling studies made
a firm prediction that a glucopyranose analogue of hydantocidin would bind to and might strongly
inhibit, glycogen phosphorylase. In order to confirm this hypothesis, Fleet and co-workers tackled the
synthesis of the spirohydantoins of glucopyranose from the methyl ester 77 [50]. Treatment of 77 [51]
Molecules 2017, 22, 2028 11 of 35
with lithium bis(trimethylsilyl)amide and carbon tetrabromide gave an intermediate bromide, which
was transformed into the ureas 79 and 80 via intermediate amines 78 (Scheme 14). Unlike in the case of
the ribofuranosyl hydantoins, once the nitrogen of the quaternary anomeric centre has been acylated,
there is no longer a kinetically easy pathway for the equilibration of the anomers to take place and 79
and 80 were separated by flash chromatography. Reaction of 79 with potassium tert-butoxide afforded,
after removal of the protecting groups, glucopyranosyl hydantoin 73. Following the same synthetic
sequence, hydantoin 74 was obtained from 80. As predicted by the molecular modeling studies,
the spirohydantoin 73 is a potent inhibitor of glycogen phosphorylase, while 74 have a poor activity.
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Starting from azide 81, available on large scale from glucoheptonolactone, hydrogenation 
followed by treatment of the resulting amine with potassium cyanate in acetic acid, gave the urea 82. 
After acidic hydrolysis to the open chain derivative 83, bromine oxidation afforded the epimeric 
mixture of hydantoins 84. Since it was not possible to separate the isomers directly, the anomeric 
mixture was converted to the corresponding benzylidene acetals, which were then separated by 
column chromatography and deprotected to finally yield both anomeric hydantoins 73 and 74. 
On account of the biological activity of spirohydantoin of glucopyranose 73 as a specific inhibitor 
of the glucosyl transferase glycogen phosphorylase, it was reasonable to assume that rhamnose 
c e e 14. Glucopyranose hydantoin synthesis. Reagents and conditions: (i) 1. (Me3Si)2NLi then
CBr4, −0 ◦C; 2. NaN3, DMF, r.t., 66%; 3. H2, Pd black, MeCOOEt, r.t., 86%; (ii) KNCO, MeCOOH,
29% of 79 and 29% of 80 (iii) 1. tert-BuOK, THF; 2. H2, Pd black, EtOH, HCl, 81% of 73 and 73% of 74.
This original synthesis of glucopyranosyl hydantoin 73 was lengthy and required a separation
step, so was disadvantageous for a multi-gram preparation of the active compound. In view that
furan isomers are thermodynamically more stable than their pyranose counterparts, all the attempts
to isomerize spirofuran hydantoins to the pyranose isomers were abandoned. In turn, Fleet and
co-workers reported yet another procedure for the synthesis of both anomeric glycopyranose
hydantoins, this time from the cheap and readily available glucoheptonolactone [52] (Scheme 15).
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After acidic hydrolysis to the open chain derivative 83, bromine oxidation afforded the epimeric 
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c e e 15. Reagents and conditions: (i) H2, Pd/C, THF, r.t., 100%; (ii) KOCN, AcOH, 20 min, r.t.,
45%; (iii) AcOH, 1 h, 80 ◦C, 79%; (iv) AcOH/H2O (4:1), 1 h, 55 ◦C, 87%; (v) Br2, AcONa, MeOH;
(vi) 1. PhCH(OMe)2, TsOH, DMF; 2. AcOH/H2O (4:1), 20 min, 75 ◦C; 3. Chromatographic separation;
4. H2, Pd black, MeOH, 19% of 73, 9% of 74.
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Starting from azide 81, available on large scale from glucoheptonolactone, hydrogenation followed
by treatment of the resulting amine with potassium cyanate in acetic acid, gave the urea 82. After acidic
hydrolysis to the open chain derivative 83, bromine oxidation afforded the epimeric mixture of
hydantoins 84. Since it was not possible to separate the isomers directly, the anomeric mixture
was converted to the corresponding benzylidene acetals, which were then separated by column
chromatography and deprotected to finally yield both anomeric hydantoins 73 and 74.
On account of the biological activity of spirohydantoin of glucopyranose 73 as a specific inhibitor
of the glucosyl transferase glycogen phosphorylase, it was reasonable to assume that rhamnose
hydantoins may interact with the active site of some rhamnose processing enzymes. Fleet and
co-workers reported a route towards L-rhamnose hydantoins which includes as key step an ionic
brominative oxidation of rhamnose derivative 85 [53] to bicyclic intermediate 86, with both a nitrogen
and a carbonyl function at the anomeric position (Scheme 16) [54]. Reaction of 86 with phenyl
isocyanate and pyridine afforded the phenyl urea 87, which spontaneously cyclised on refluxing
methanol to afford the protected hydantoin 88. Acidic hydrolysis finally gave the rhamnopyranose
analogue of hydantocidin 75.
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In their continuous search for highly specific binding to enzymes or receptors involving
carbohydrates, Fleet and co-workers also described the synthesis of a galactopyranose analogue
of hydantocidin [55] (Scheme 17).
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Starting from protected nitrile 89 [56], reaction with methanolic hydrogen chloride followed
by isopropylidenation of the cis-1,2-diol and protection of the remaining hydroxy groups as
tert-butyldimethylsilyl ethers afforded ester 90. After radical bromination, intermediate bromide
was transformed into urea 92, which on tert-butoxide-induced cyclization and acidic hydrolysis
afforded the desired galactopyranose analogue of hydantocidin 76.
2.2.3. Carbocycles
Since (+)-hydantocidin possess a N,O-hemiacetal functionality at the anomeric position, it could
be easily isomerized to the more thermodynamically stable 5-epimer. In order to avoid epimerization,
a series of carbocyclic analogues were synthetized (Figure 6).
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The first synthesis of a carbocyclic hydantoin was reported by Fleet et al. in 1993 [57]. 
Intramolecular aldol reaction of aldehyde 99, prepared from readily available azidodiol 98 [58], 
afforded bicyclic azidolactone 100 (Scheme 18). This lactone was converted into hydantoin 93 via the 
corresponding urea 101. 
 
Scheme 18. Reagents and conditions: (i) HIO4, THF, r.t., quant; (ii) KF, 18-crown-6, CH3CN, −6 °C, 
58%; (iii) 1. H2, Pd black, aq. EtOH, r.t., 83%; 2. KOCN, AcOH, r.t., 90%; (vi) HCl, MeOH, r.t., quant. 
The same researchers described the synthesis of a cyclohexane analogue of hydantocidin [59]. 
Thus, treatment of the azidosulphate 102 [60] with sodium hydride induced intramolecular cyclisation 
to azidolactone 103 (Scheme 19). From lactone 103, the cyclohexane analogue of hydantocidin 94 was 
easily available following a synthetic sequence involving hydrogenation, formation of the urea and 
acidic hydrolysis. 
Later in 1995, Sano et al. reported the synthesis of the carba-analogue of hydantocidin 95, in 
which the oxygen atom of the D-ribose unit has been replaced by a methylene unit. After finding that 
the racemic carba-hydantocidin maintained the herbicidal activity [61], they focused on the synthesis 
of the optically active compound, which was prepared from easily available D-gulono-l,4-lactone [62]. 
Oxidative cleavage of gulonolactone 104 with sodium periodate, followed by formation of an 
intermediate isopropyl acetal and reaction with dimethyl methylphosphonate and n-butyl lithium, 
afforded cyclopentenone 105 (Scheme 20). Conjugate 1,4-addition of benzyl β-hydroxymethyl anion 
gave cyclopentanone 106 as a single isomer. Reaction of 106 with potassium cyanide, followed by 
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The first synthesis of a carbocyclic hydantoin was reported by Fleet et al. in 1993 [57].
Intramolecular aldol reaction of aldehyde 99, prepared from readily available azidodiol 98 [58],
afforded bicyclic azidolactone 100 (Scheme 18). This lactone was converted into hydantoin 93 via the
corresponding urea 101.
Molecules 2017, 22, 2028 13 of 35 
 
2.2.3. Carbocycles 
Since (+)-hydantocidin possess a N,O-hemiacetal functionality at the anomeric position, it could 
be easily isomerized to the more thermodynamically stable 5-epimer. In order to avoid epimerization, 
a series of carbocyclic analogues were synthetized (Figure 6). 
 
Figure 6. Carbocyclic analogues of hydantocidin. 
 fi     li  t i  as r rte  by Fleet et al. i  1993 [57]. 
 l i    , r  f  il  il l  i i l 9  [ ], 
               
   
 
Scheme 18. Reagents and conditions: (i) HIO4, THF, r.t., quant; (ii) KF, 18-crown-6, CH3CN, −6 °C, 
58%; (iii) 1. H2, Pd black, aq. EtOH, r.t., 83%; 2. KOCN, AcOH, r.t., 90%; (vi) HCl, MeOH, r.t., quant. 
The same researchers described the synthesis of a cyclohexane analogue of hydantocidin [59]. 
Thus, treatment of the azidosulphate 102 [60] with sodium hydride induced intramolecular cyclisation 
to azidolactone 103 (Scheme 19). From lactone 103, the cyclohexane analogue of hydantocidin 94 was 
easily available following a synthetic sequence involving hydrogenation, formation of the urea and 
acidic hydrolysis. 
Later in 1995, Sano et al. reported the synthesis of the carba-analogue of hydantocidin 95, in 
which the oxygen atom of the D-ribose unit has been replaced by a methylene unit. After finding that 
the racemic carba-hydantocidin maintained the herbicidal activity [61], they focused on the synthesis 
of the optically active compound, which was prepared from easily available D-gulono-l,4-lactone [62]. 
Oxidative cleavage of gulonolactone 104 with sodium periodate, followed by formation of an 
intermediate isopropyl acetal and reaction with dimethyl methylphosphonate and n-butyl lithium, 
afforded cyclopentenone 105 (Scheme 20). Conjugate 1,4-addition of benzyl β-hydroxymethyl anion 
gave cyclopentanone 106 as a single isomer. Reaction of 106 with potassium cyanide, followed by 
. t iti : (i) I 4, , .t., t; (ii) F, 18-crown-6, CH3 , ◦ ,
; iii . 2, lac , a . Et , r.t., ; . , c , r. ., ; i l, , . ., .
The same researchers described the synthesis of a cyclohexane analogue of hydantocidin [59].
Thus, treatment of the azidosulphate 102 [60] with sodium hydride induced intramolecular cyclisation
to azidolactone 103 (Scheme 19). From lactone 103, the cyclohexane analogue of hydantocidin 94 was
easily available following a synthetic sequence involving hydrogenation, formation of the urea and
acidic hydrolysis.
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of sugar derivatives to generate the desired stereochemistry of the hydroxyl groups in the furan ring. 
However, Pham and co-workers reported the preparation of carbocyclic hydantocidins 96 and 97 
from ethyl 2-butynoate and N,N′-diprotected-5-methylenehydantoins using as key step a phosphine-
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Later in 1995, Sano et al. reported the synthesis of the carba-analogue of hydantocidin 95, in which
the oxygen atom of the D-ribose unit has been replaced by a methylene unit. After finding that the
racemic carba-hydantocidin maintained the herbicidal activity [61], they focused on the synthesis of the
optically active compound, which was prepared from easily available D-gulono-l,4-lactone [62]. Oxidative
cleavage of gulonolactone 104 with sodium periodate, followed by formation of an intermediate
isopropyl acetal and reaction with dimethyl methylphosphonate and n-butyl lithium, afforded
cyclopentenone 105 (Scheme 20). Conjugate 1,4-addition of benzyl β-hydroxymethyl anion gave
cyclopentanone 106 as a single isomer. Reaction of 106 with potassium cyanide, followed by treatment
of the resulting aminonitrile 107 with chlorosulfonyl isocyanate afforded, after removal of the
protecting groups, optically active carbocyclic analogue 95.
Molecules 2017, 22, 2028 14 of 35 
 
treatment of the resulting aminonitrile 107 with chlorosulfonyl isocyanate afforded, after removal of 
the protecting groups, optically active carbocyclic analogue 95. 
 
Sch me 19. Reage ts and conditions: (i) NaH, DMF then H+/H2O, 59%; (ii) 1. TFA/H2O, 70%; 2. H2, 
10% Pd/C, EtOH, quant; (iii) 1. KOCN, AcOH, 87%; 2. HCl, MeOH, 88%. 
 
Scheme 20. Reagents and conditions: (i) NaIO4, NaOH, H2O, r.t.; (ii) p-TsOH-Py, i-PrOH, 90 °C, 51%; 
(iii) MeP(O)(OMe)2, n-BuLi, THF, −8 °C to r.t., 51%; (iv) (BnOCH2)2CuBr 2Li Me2S, TMSCl, −8 °C to 
r.t., 99%; (v) KCN, NH4Cl; (vi) ClSO2NCO, CH2Cl2 then HCl 1 M, 100 °C, 64%; (vii) H2, Pd/C, MeOH, 
55 °C, 98%. 
N
NBn
O
O
Bn
Me CO2Et
+
N
N
Bn
O
O Bn
EtO2Ci
108
109 110
N
N
Bn
O
O Bn
EtO2C
111
+
ii
iii, iv
NH
N
H
O
O
96
HO
HO
OH
NH
N
H
O
O
97
HO
HO
OH
 
Scheme 21. Reagents and conditions: (i) Bu3P, toluene, r.t; (ii) 1. KN(TMS)2, THF, −8 °C, 10 min; 2. 
HOAc, −8 °C to r.t., 99%; (iii) 1. 10% HCl, MeCN, 90 °C, 15 h, 99%; 2. BH3.DMS, THF, 0 °C, 6 h, 95%; 
3. K2OsO4.2H2O, NMO, acetone/H2O (4:1), r.t., 5 days, 37%; 4. Ac2O, pyridine, MeCN, r.t., 10 h, 91%; 
(iv) 1. NBS, C6H5Cl, 125 °C, 14 h; 2. 10% HCl, THF, reflux, 4 h, 95–99%. 
Most of the reported syntheses of hydantocidin and its analogues have revolved around the use 
of sugar derivatives to generate the desired stereochemistry of the hydroxyl groups in the furan ring. 
However, Pham and co-workers reported the preparation of carbocyclic hydantocidins 96 and 97 
from ethyl 2-butynoate and N,N′-diprotected-5-methylenehydantoins using as key step a phosphine-
catalysed [3 + 2]-cycloaddition to generate the spiro-heterocyclic system (Scheme 21) [63]. Thus, the 
cycloaddition reaction of the 5-methylenehydantoin 108 with the ylide that was generated in situ 
. t iti : (i) I 4, a , 2O, r.t.; (ii) p-Ts - , i- , ◦ , ;
( )( )2, , , − ◦ .t., 51 ; (iv) (Bn CH2)2 2 i e2 , T S l, ◦
. ., ; ( ) , 4 l; (vi) lS 2 , 2 2 ◦ ; ( ii) 2 , e ,
◦
Most of the reported syntheses of hydantocidin and its analogues have revolved around the
use of sugar derivatives to generate the desired stereochemistry of the hydroxyl groups in the
furan ring. However, Pham and co-workers reported the preparation of carbocyclic hydantocidins
96 and 97 from ethyl 2-butynoate and N,N′-diprotected-5-methylenehydantoins using as key step
a phosphine-catalysed [3 + 2]-cycloaddition to generate the spiro-heterocyclic system (Scheme 21) [63].
Thus, the cycloaddition reaction of the 5-methylenehydantoin 108 with the ylide that was generated in
situ from the reaction of ethyl 2-butynoate 109 and tributylphosphine afforded est r 110, whic was
then isom zed to ester 111 on treatment with potassium bistrimethylsi ylamide. Acid catalysed
hydrolysis of the ester gr up of 111, followed by reduction and cis-dihydroxylation affor ed,
after removal of the protecting grou s, carbocyclic hyda toins 96 and 97.
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Most of the reported syntheses of hydantocidin and its analogues have revolved around the use 
of sugar derivatives to generate the desired stereochemistry of the hydroxyl groups in the furan ring. 
However, Pham and co-workers reported the preparation of carbocyclic hydantocidins 96 and 97 
from ethyl 2-butynoate and N,N′-diprotected-5-methylenehydantoins using as key step a phosphine-
catalysed [3 + 2]-cycloaddition to generate the spiro-heterocyclic system (Scheme 21) [63]. Thus, the 
cycloaddition reaction of the 5-methylenehydantoin 108 with the ylide that was generated in situ 
. ea ents and conditions: (i) Bu3P, toluene, r.t; (ii) 1. KN(TMS)2, THF, −8 ◦C, 10 min;
2. HOAc, −8 ◦C to r.t., 99%; (iii) . 10% HCl, MeCN, 90 ◦C, 15 h, 9%; 2. BH3.DMS, THF, 0 ◦C, 6 h, 95 ;
. 2 4.2 2O, NMO, acetone/H2O (4:1), r.t., 5 days, 37%; 4. Ac2O, pyridine, MeCN, r.t., 10 , ;
6 5Cl, 125 ◦C, 14 h; 2. 10% HCl, THF, reflux, 4 h, 95–99 .
2.3. odifications of Hydantocidin in the Hydantoin Ring
In order to shed some light on the functionalities required for the herbicidal action of hydantocidin,
researchers also focused on the synthesis of structural analogues of hydantocidin resulting from
modifications in the hydantoin ring of the parent molecule (Figure 7).
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D-erythronolactone 118 (Scheme 22) [64]. Addition of lithium trimethylsilylacetylide gave 119, which 
on acetylation and treatment with ethyl N-benzyloxycarbamate in the presence of sodium hydride 
and trimethylsilyl triflate, led to the formation of 120. Removal of the TMS group and hydrogenation 
of the triple bond under Lindlar conditions gave the anomeric C-vinyl derivative, which on ozonolysis, 
oxidation of the resulting aldehyde and amidation with PyBroP afforded the corresponding anomeric 
amide 121. Treatment of 121 with TBAF gave, after removal of the protecting groups, the intended 
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Figure 7. Analogues of hyda t ified in the hydantoin ring.
For example, anticipating that the presence of a N-hydroxy group could provide a site for possible
H-bonding and a polar environment on theβ-face of the molecule, Hanessian and co-workers described
the preparation of a N-hydroxyspirohydantoin 112 from readily available D-erythronolactone 118
(Scheme 22) [64]. Addition of lithium trimethylsilylacetylide gave 119, which on acetylation and
treatment with ethyl N-benzyloxycarbamate in the presence of sodium hydride and trimethylsilyl
triflate, led to the formation of 120. Re oval of the TMS gr up and ydrogenation of the triple bond
under Lindlar co itions gave the an meric C-vinyl derivative, which on ozonolysis, xidation of
the resulting aldehyde and ami ation with PyBroP afforded the cor esponding anomeric amide 121.
Treatment of 121 with TBAF gave, after removal of the pr tecting groups, the intended hydantocidin
analog 112.
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Scheme 22. Reagents and conditions: (i) LiC 2 ; (i ) BnONHCO2Et, NaH, TfOTMS;
(iv) 1. TBAF, THF; 2. H2, Pd/BaSO4, quinoline, 71%; (v) O3, CH2Cl2 th n SMe2; (vi) 1. NaClO2,
NaHPO4, 2-methyl-2-butene, t-BuOH, H2O; 2. PyBroP, NH3; (vii) TBAF, THF; (viii) 1. Dowex-H+;
2. H2, Pd/C, 83%.
It was soon clear that drastic derivatization only led to diminished herbicidal activity, so attention
of researchers turned to minimum modification without changing the basic structure. In this
regard, Sano and co-workers described the first thiohydantoine derivative, in which the C7
carbonyl group was replaced with a thiocarbonyl group (compounds 113 and 114) [65]. Starting
with D-psicofuranose derivative 122 [38], selective cleavage of the exocyclic diol, followed by
stereoselective introduction of an azide group in the anomeric position, afforded azide 123 (Scheme 23).
Oxidation to the corresponding carboxylic acid, followed by coupling with ammonia, gave azide 124.
Spirothiohydantoin ring formation at the anomeric position was achieved by treatment of 124 with
tri-n-butylphosphine and carbon disulfide affording, after acidic hydrolysis, spirothiohydantoin 113
along with its epimer 114.
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thiohydantoins [68–71]. For example, Scheme 25 displays the synthesis of thiohydantoin 116 from  
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The observation that the introduction of the sulfur atom did not affect the herbicidal activity,
sparkled the interest in thio analogues of hydantocidin. Thus, a number of analogues belonging
to the family of thiohydantoins were described in the past few years. In an attempt to design
analogues of hydantocidin which are more resistant to isomerisation, Lamberth and co-workers
Molecules 2017, 22, 2028 17 of 35
described the synthesis of a mimic of hydantocidin in which the hydantoin moiety was replaced
by a thiazolidondione (compound 115, Scheme 24) [66]. Photobromination of the readily available
nitrile 125 [67] gave the bromo-ribosyl cyanide 126, with on reaction thiourea and acidic hydrolysis
afforded spiro-thiazolidindione 115.
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Somsák and co-workers developed an efficient general procedure for the short synthesis of
thiohydantoins [68–71]. For example, Scheme 25 displays the synthesis of thiohydantoin 116 from
D-galactopyranosyl cyanide 128 [72]. Thus, TiCl4 promoted addition of water to the nitrile moiety
afforded formamide 129, which on nucleophilic displacement of the bromide with silver thiocyanate
followed by deacetylation furnished the pyranose thiohydantocidin 116.
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3. Synthesis of Diketopiperazine Analogues
As seen in the previous section, the bioactivity of hydantocidin has prompted extensive synthetic
studies towards hydantocidin itself and a variety of its analogues. Additional preparative work
has focused on the substitution of the hydantoin ring for other spiroheterocyclic subunits. In this
regard, the potential of diketopiperazine analogues has not escaped attention. Diketopiperazines,
both naturally occurring [75] and synthetic [76], are a class of bioactive peptides with a range of
chemotherapeutic applications [77]. Given their biological relevance and in the search for novel
mimics of hydantocidin, several syntheses of diketopiperazine analogues of hydantocidin were
reported (Figure 8).
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Figure 8. Analogues of hyda t t i ing a diketipiperazine ring.
In this regard, Fleet and co-workers extensively investigated the incorporation of
a spirodiketopiperazine ring into the anomeric position of furanose and pyranose sugars [78,79].
Thus, on reaction with Cbz-glycine, amino ester 140 [80] isomerizes to the ore nucleophilic amine
intermediate before the actual coupling reaction, affording dipeptide 141 as the major product
(Scheme 27). Removal of the Cbz-protecting group, followed by reaction with potassium tert-butoxide
gave, after acidic hydrolysis, the desired spiro compound 133.
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In an attempt to access the mannopyranose derivative, a slightly different strategy was used [81].
Coupling of the amine 143 with Cbz-glycine afforded derivative 144. After selective removal of the
exocyclic isopropylidene protecting group, oxidation with N-bromophthalimide afforded bicycle 146.
(Scheme 28).
Removal of the benzyloxycarbonyl protecting group on hydrogenation was accompanied by
spontaneously cyclisation of the resulting amine to give the spirodiketopiperazine 147. However,
acidic hydrolysis of 147, followed by reaction with potassium tert-butoxide, gave mannofuranose
diketopiperazine 133, which is more stable than the corresponding mannopyranose derivative.
In connection with their work aimed to discover efficient inhibitors of glycogen phosphorylase as
possible therapeutic agents for the treatment of diabetes, Fleet and co-workers reported the synthesis of
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glucopyranosyl spirodiketopiperazine 134, analogue of the bioactive glucopyranose hydantoin 73 [82].
Thus, coupling of lactone 148 with Cbz-glycine, followed by acidic hydrolysis and spontaneous
cyclization, afforded the bicyclic lactone 150 (Scheme 29). Transfer hydrogenation of 150 gave a free
amine which, on spontaneous cyclization yielded the spirodiketopiperazine 151. Further transfer
hydrogenation gave the required unprotected spiro compound 134.
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spirodiketopiperazine ring, coupling of the mixture of epimeric aminoesters 156 with Cbz-glycine 
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Fleet and co-workers also developed the synthesis of rhamnofuranose-derived
diketopiperazines [54]. The aminoester 152 [83] was coupled with Cbz-glycine activated as
a mixed anhydride with ethyl chloroformate, to give the dipeptide 153 in which the configuration
at the anomeric centre has been retained (Scheme 30). Removal of the Cbz-protecting group gave
an intermediate amine which spontaneously cyclised to the corresponding diketopiperazine, finally
affording derivative 135 after acidic hydrolysis.
On the other hand, when Cbz-glycine was activated by DCC (N,N′-dicyclohexylcarbodiimide), the
major product from coupling with the amine 152 was the dipeptide 154. In the case of DCC activation,
the carbonyl group is less electrophilic than is the case in activation by ethyl chloroformate. Thus, must
equilibrate to the less stable, but more reactive, amine prior to acylation. Following a similar synthetic
procedure as in the case of 153, epimeric spirodiketopiperazine 136 was prepared from dipeptide 154.
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More recently, Feet et al. reported the synthesis of anomeric spirodiketopiperazines derived
from 6-deoxy-L-lyxofuranose [48]. Using their established methodology for the construction of the
spirodiketopiperazine ring, coupling of the mixture of epimeric aminoesters 156 with Cbz-glycine
afforded epimeric dipeptides 157 and 158 (Scheme 31). Hydrogenolysis of the benzyloxycarbonyl
protecting group in 157 gave the corresponding amine, which cyclized upon treatment with t-BuOK
to afford, after acidic hydrolysis, the spirodiketopiperazine compound 137. The same sequence was
applied to dipeptide 158 to afford epimeric spirocyclic sugar 138.Molecules 2017, 22, 2028 20 of 35 
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After the pioneering work of Fleet’s group, other synthetic procedures have been developed for 
the preparation of different anomeric spirodiketopiperazines. For example, 2,3-dideoxy derivative 
139 was synthesized using a procedure featuring an acid-catalyzed rearrangement of a 3-hydroxy β-
lactam and the ammonolysis of a spiro keto lactone (Scheme 32) [84]. Starting from hydroxyazetidinone 
159, isomerization with PPTS gave derivatives 160 and 161. Baeyer-Villiger oxidation the spiro 
system, followed by ammonolysis, yielded the lactol amide 162 as a 1:1 mixture of epimers. Ring 
closure and desilylation finally afforded diketopiperazine 139. 
 
Scheme 32. Reagents and conditions: (i) PPTS, DCM; (ii) m-CPBA, NaHCO3, DCM, 93%; (iii) NH3, 
MeOH, 100%; (iv) PPTS, benzene, 4 Å molecular sieves; (v) TBAF, THF, 100%. 
4. Synthesis of Barbiturate Analogues 
A relevant problem with hydantoins and diketopiperazines is their lack of stability, mainly due 
to facile anomeric epimerization in basic media. To avoid epimerization around C-1′, hydantoin or 
diketopiperazine rings can be replaced by a barbiturate ring. Like the hydantoin ring, the barbiturate 
ring system possesses thymine-like hydrogen bonding capacity against adenine derivatives [85] and 
is found in many pharmaceutically relevant molecules [86]. In 2002, Renard and collaborators 
reported the synthesis of a spiro-barbituric deoxyribofuranose and its carbocyclic analogue from 
carbohydrate derivatives [87]. Erythrolactol 165 was condensed with barbituric acid in the presence 
of sodium carbonate to give the erythrosyl barbituric acid derivative 166 (Scheme 33). After 
hydrogenolysis, bromination of intermediate alcohol 167 in the presence tert-butyldimethylsilyl 
c . eagents and con itions: (i) Cbz-Gly-O , C , 1-hydroxybenzotriazole, dichloro et a e,
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After the pioneering work of Fleet’s group, other synthetic procedures have been developed for
the preparation of different anomeric spirodiketopiperazines. For example, 2,3-dideoxy derivative 139
was synthesized using a procedure featuring an acid-catalyzed rearrangement of a 3-hydroxy β-lactam
and the ammonolysis of a spiro keto lactone (Scheme 32) [84]. Starting from hydroxyazetidinone 159,
isomerization with PPTS gave derivatives 160 and 161. Baeyer-Villiger oxidation the spiro system,
followed by ammonolysis, yielded the lactol amide 162 as a 1:1 mixture of epimers. Ring closure and
desilylation finally afforded diketopiperazine 139.
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MeOH, 100%; (iv) PPTS, benzene, 4 Å molecular sieves; (v) TBAF, THF, 100%.
4. Synthesis of Barbiturate Analogues
A relevant problem with hydantoins and diketopiperazines is their lack of stability, mainly due
to facile anomeric epimerization in basic media. To avoid epimerization around C-1′, hydantoin or
diketopiperazine rings can be replaced by a barbiturate ring. Like the hydantoin ring, the barbiturate
ring ystem possesses thymine-like hydrogen bonding capacity against adenine derivatives [85] and is
found in many pharmaceutically elevan molecules [86]. In 2002, Renard and collaborators reported
the synthesis of a spiro-barbituric deoxyrib furanose and its carbocyclic analogue from carbohydrate
derivatives [87]. Erythrolactol 165 was condensed with barbituric acid in the presence of sodium
carbonate to give the erythrosyl barbituric acid derivative 166 (Scheme 33). After hydrogenolysis,
bromination of intermediate alcohol 167 in the presence tert-butyldimethylsilyl chloride afforded
derivative 168. Silyl deprotection finally gave the desired spiro-barbituric deoxyribofuranose 169.
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5. Synthesis of Miscellaneous Spiroheterocyclic Units 
On addition to diketopiperazines and barbiturates, several other hydantocidin analogues with 
very diverse spiroheterocyclic rings were synthetized, as depicted in Figure 9. For example, in order 
to study the direction of the hydrogen bonding of the hydantoin, a spirodihydrouracil analogue of 
(+)-hydantocidin was developed [88]. Starting from mixture on nitriles 191, reduction with lithium 
aluminium hydride afforded aminoalcohol 192, which was N-carbonylated to give carbamates 193 
and 194 (Scheme 35). Oxidation of the alcohol 193 to the corresponding carboxylic acid followed by 
condensation with ammonia provided amide 196. The base-promoted intramolecular cyclization of 
196 gave, after removal of the protecting groups, the spirodihydrouracil 175. 
Scheme 33. Reagents and conditions: (i) barbituric acid, Na2CO3, H2O, 59%; (ii) H2, Pd-C, MeOH,
91%; (iii) Br2, TBDMSCl, imidazole, DMF, 63%; (iv) TMSCl, MeOH, 95%.
In order to enhance the stability of derivative 169, the synthesis of a carba-sugar analogue was
also described. Prins reaction of cyclopentene diester 170, followed by pancreatin-catalyzed resolution
(25%, ee > 98%) of the resulting racemic diol, aff rded he optically pure di l 171 (Scheme 34). Silylation
and condens tion with urea aff rded the spiro-barbituric acid 173, which on deprotection of the silyl
groups gave the desired carbocyclic analogue 174.
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ClCO2Et, then NH3, 0 °C, 91%; (v) NaN(TMS)2, n-Bu4NF, THF, r.t., 86%; (vi) 1. Dowex, 50 W; 2. H2, 
Pd-C, r.t., 100%. 
Sano et al. prepared several hydantocidin analogues including modifications on the carbonyl 
groups of the hydantoin ring [89]. For example, spiroimidazolidinone 176 was synthesized using a 
demethyldesulfurization as key step (Scheme 36). Thus, compound 197 [36] was converted to the 
mixture of epimeric thioacetals 199, which on radical demethylsulfurization afforded compound 200. 
The final 3 steps consisted of the removal of the protecting groups, to finally afford analogue 176. 
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The synthesis of a spiroimidazolinone analogue of hydantocidin was also described (Scheme 37).
Treatment of azido amide 201 with benzyl isocyanate and tri-n-butylphosphine afforded the spiro
compound 202, which on acid hydrolysis and hydrogenolysis gave desired spiroimidazolinone 177.
Gasch and collaborators reported the stereoselective synthesis of a wide range of pyranoid
and furanoid spiroheterocyclic analogues of hydantocidin [90,91]. Thus, reaction of psicofuranose
spiroketal 203 with trimethylsilyl isothiocyanate in the presence of trimethylsilyl triflate provided
the corresponding O-protected thioxo-oxazolidine 204 (Scheme 38). The N-glycosylation of 203 with
trimethylsilyl isothiocyanate in the presence of a Lewis acid afforded the mixture of oxazolidines 178a
and 178b. For the synthesis of spiro-C-glycosides, spiroketal 203 was transformed into psicofuranosyl
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cyanides 205 and 206 according to Sano’s procedure [88]. Reduction of psicofuranosyl cyanide 205 with
lithium aluminium hydride, followed by treatment with thiophosgene, afforded isothiocyanate 207,
which on treatment with triethylamine afforded the intramolecular cycloadduct 179. Similarly,
compound 180 was obtained from 206. The reaction of 203 with (trimethylsilyl)acetonitrile afforded
two products of the nucleophylic attack on the anomeric carbon, via either the nitrogen atom (N-attack)
or the methylenic carbon (C-attack). The N-attack forms a heterocumulene intermediate 209, whereas
the C-attack produces intermediate nitrile 210; both intermediates undergo intramolecular cyclization
to finally afford 181 and 182.
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Additional work allowed the preparation of other 6 + 5, 6 + 6 spironucleosides and spiro-C-
glycosides from spiroketal derivative 211 (Scheme 39). N-glycosylation of 211 with trimethyl azide 
afforded 212, as a 9:1 anomeric mixture. Pd-catalyzed hydrogenation of 212, followed by treatment 
of the intermediate amine 213 with TBAF and thiocarbonyldiimidazole afforded spironucleoside 183. 
C-glycosylation of 211 with trimethylcyanide in the presence of trimethylsilyltriflate, followed by 
desilylation with TBAF gave the fructopyranolsyl cyanide 214. Reduction with lithium aluminium 
hydride, followed by reaction with thiocarbonyl diimidazole and triethylamine-promoted 
intramolecular cyclization, provided compound 184. Finally, reaction of 211 with 
trimethylsilylacetonitrile in the presence of trimethylsilyltriflate afforded derivative 185. 
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Additional work allowed the preparation of other 6 + 5, 6 + 6 spironucleosides and
spiro-C-glycosides from spiroketal derivative 211 (Scheme 39). N-glycosylation of 211 with
trimethyl azide afforded 212, as a 9:1 anomeric mixture. Pd-catalyzed hydrogenation of 212,
followed by treatment of the intermediate amine 213 with TBAF and thiocarbonyldiimidazole
afforded spironucleoside 183. C-glycosylation of 211 with trimethylcyanide in the presence of
trimethylsilyltriflate, followed by desilylation with TBAF gave the fructopyranolsyl cyanide 214.
Reduction with lithium aluminium hydride, followed by reaction with thiocarbonyl diimidazole and
triethylamine-promoted intramolecular cyclization, provided compound 184. Finally, reaction of 211
with trimethylsilylacetonitrile in the presence of trimethylsilyltriflate afforded derivative 185.Molecules 2017, 22, 2028 25 of 35 
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Also related to spironucleosides are the recently described spiro-oxazoline furanosides 186 [92] 
Their synthesis was achieved using a TMSOTf-promoted nucleophilic addition of electron-rich 
nitriles to the oxacarbenium ion intermediate of reaction of protected psicofuranose derivative 215 
(Scheme 40). In addition to their pharmacological interest, spiro-fused carbohydrate oxazoline 
derivatives have potential applications in asymmetric catalysis [93]. 
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As a variation of the spirodiketopiperazine skeleton, the spiro-derivative 187 was recently 
prepared from carbohydrate lactones in a route involving N-glycosylation of ulosonic acid esters [94]. 
Thus, an indium-mediated Reformatsky reaction of mannonolactone diacetonide 216 with ethyl  
α-bromoisobutyrate gave ulosonate 217 (Scheme 41). N-glycosylation of compound 217 was achieved 
by acetylation followed by reaction with trimethylsilyl azide in the presence of trimethylsilyl triflate, 
affording azide 218 diastereoselectively. Catalytic hydrogenation and treatment of the resulting 
anomeric mixture of amino esters with phenyl isocyanate afforded derivative 219 as a single anomer. 
Basic treatment of urea 219 easily gave the corresponding diketopiperazine 187 without any 
equilibration of anomers taking place. 
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Also related to spironucleosides are the recently described spiro-oxazoline furanosides 186 [92]
Their synthesis was achieved using a TMSOTf-promoted nucleophilic addition of electron-rich nitriles
to the oxacarbenium ion intermediate of reaction of protected psicofuranose derivative 215 (Scheme 40).
In addition to their pharmacological interest, spiro-fused carbohydrate oxazoline derivatives have
potential applications in asymmetric catalysis [93].
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As a variation of the spirodiketopiperazine skeleton, the spiro-derivative 187 was recently
prepared from carbohydrate lactones in a route involving N-glycosylation of ulosonic acid esters [94].
Thus, an indium-mediated Reformatsky reaction of mannonolactone diacetonide 216 with ethyl
α-bromoisobutyrate gave ulosonate 217 (Scheme 41). N-glycosylation of compound 217 was achieved
by acetylation followed by reaction with trimethylsilyl azide in the presence of trimethylsilyl triflate,
affording azide 218 diastereoselectively. Catalytic hydrogenation and treatment of the resulting
anomeric mixture of amino esters with phenyl isocyanate afforded derivative 219 as a single
anomer. Basic treatment of urea 219 easily gave the corresponding diketopiperazine 187 without
any equilibration of anomers taking place.Molecules 2017, 22, 2028 26 of 35 
 
 
Scheme 41. Reagents and conditions: (i) In, BrC(CH3)2CO2Et, THF, US, r.t; (ii) 1. Ac2O, Et3N, CH2Cl2, 
r.t., 14 h; 2. TMSN3, TMSOTf, powdered MS, CH2Cl2, r.t., 14 h, 71%; (iii) 1. Pd/C, MeOH, r.t., 14 h; 2. 
PhCNO, toluene, r.t., 3 h, 85%; (iv) NaOMe, r.t., 14 h, quant. 
Maza et al. recently reported the first selenium-containing (+)-hydantocidin analogues [95]. 
Starting from N-arylfructosamine 220, reaction with phenyl isoselenocyanate afforded the corresponding 
imidazolidine-2-selone 221, which underwent dehydration under weak acidic conditions to give 
spiranic derivative 188 as a major compound (Scheme 42). 
O
HO N
N
Se
188
HO
HO
OH
OH
OH
O
NHPMP
220
i
HO
OH
HO
OH
221
N
N
HO
Ph
PMP
Se
ii
HO
OH
HO
OH
222
N
N
Ph
PMP
Se
OH
PMP
Ph
+
 
Scheme 42. Reagents and conditions: (i) PhNCSe, DMF, r.t., 72 h, 98%; (ii) AcOH, EtOH/H2O (2:1), 
reflux, 1 h, 39% of 222 and 60% of 188. 
Taillefumier and co-workers reported the first synthesis of 1,4-diazepine 2,5-dione anomeric 
spirosugars, which can be regarded as the first members of a new class of spironucleosides [96]. 
Michael addition of benzylamine to glycal 223 [97], followed by hydrogenation and coupling of the 
resulting free amine with Cbz-Ala-OH, afforded dipeptide 225. After protecting group removal, base 
cyclization of dipeptide 225 on high dilution gave diazepine 189 (Scheme 43). 
In 2008, Nakahara et al. reported the synthesis of a carbocyclic spiroimidazoline from D-glucose 
[98]. Nucleophilic addition of dichloromethyllithium to ketone 226 afforded branched cyclopentitol 
227, which was then converted to azido aldehyde 228 on treatment with sodium azide (Scheme 44). 
Introduction of the second nitrogen atom of the imidazoline ring was achieved by reductive 
amination of 228. After hydrogenation, condensation of the resulting diamine 229 with benzaldehyde 
using N-bromosuccinimide gave desired imidazoline 190. 
Scheme 41. Reagents and conditions: (i) In, BrC(CH3)2CO2Et, THF, US, r.t; (ii) 1. Ac2O, Et3N, CH2Cl2,
r.t., 14 h; 2. TMSN3, TMSOTf, powdered MS, CH2Cl2, r.t., 14 h, 71%; (iii) 1. Pd/C, MeOH, r.t., 14 h; 2.
PhCNO, toluene, r.t., 3 h, 85%; (iv) NaOMe, r.t., 14 h, quant.
Maza et al. recently reported the first selenium-containing (+)-hydantocidin analogues [95].
Starting from N-arylfructosamine 220, r action with phenyl isoseleno ya ate afforded the
correspo ding imidazolidine-2-selone 221, which underwent dehydration under weak acidic
conditions to give spiranic derivative 188 as a major compound (Scheme 42).
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Taillefumier and co-workers reported the first synthesis of 1,4-diazepine 2,5-dione anomeric
spirosug rs, which can be regarded as the first m mbers of a new class of spironucleoside [96].
Michael addition of b nzylamine to glycal 223 [97], followed by hyd genation and coupling of the
resulting free amin with Cbz-Ala-OH, afforded dip tide 225. Aft r protecting group removal,
base cyclization of dipeptide 225 on hig dilution gave diazepine 189 (Scheme 43).
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Other carbohydrate derivatives containing spirocycles in the anomeric position described in the 
literature include spirolactones [99], spiroaminals [100,101], spiroazacycles [102] and spirosulfamidates 
[103]. As their structural resemblance to spironucleosides is just anecdotal, these derivatives are 
outside of the scope of this review.  
6. Polycyclic Spironucleosides 
A number of spironucleosides in which the nucleobase is attached to the anomeric position of 
the sugar giving rise to a polycyclic system have been described. Such molecules provide 
conformationally fixed models, which can be useful to elucidate the glycosidic torsion angle of 
nucleosides (Figure 10). 
Early work from Zavgorodny resulted in the development of two synthetic routes to prepare 
syn-like anhydronucleosides modified at the C-1′ position of the 2-α-D-psicofuranosides [104]. 
Heating the starting compound psicofuranosyl cytosine 235 [105] with a solution of mercury (II) 
acetate followed by iodomercuration of the resulting intermediate afforded the iododinated 
compound 236, which was then converted on nucleoside 230 on treatment with potassium tert-
butoxide in DMSO (Scheme 45). 
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In 2008, Nakahara et al. reported the synthesis of a carbocyclic spiroimidazoline from
D-glucose [98]. Nucl ophilic addition of dichloromethyllithium to ketone 226 afforded branched
cyclopentitol 227, which was then converted to azido aldehyde 228 on treatment with sodium azide
(Scheme 44). Introduction of the second nitrogen atom of the imidazoline ring was achieved by
reductive amination of 228. After hydrogenation, condensation of the resulting diamine 229 with
benzaldehyde using N-bromosuccinimide gave desired imidazoline 190.
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Other carbohydrate derivatives containing spirocycles in the anomeric position described
in the literature include spirolactones [99], spiroaminals [100,101], spiroazacycles [102] and
spirosulfamidates [103]. As their structural resemblance to spironucleosides is just anecdotal, these
derivatives are outside of the scope of this review.
6. Polycyclic Spironu leosides
nu ber of spironucleosides in which the nucleobase is attached to the anomeric position of the
sugar giving rise to a polycyclic system have been described. Such molecules provide conformationally
fixed models, which can be useful to elucidate the glycosidic torsion angle of nucleosides (Figure 10).
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Gimisis and collaborators reported the synthesis of a spyronucleoside containing a remarkably 
stable orthoamide modification of the C-1′ anomeric position [106]. Starting from uridine 239 [107], 
silylation and hydroxymethylation afforded compound 240, which under Suárez conditions 
afforded, after deprotection of the silyl groups, derivative 232 (Scheme 47). 
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Figure 10. Polycyclic spironucleosides.
Early work from Zavgorodny resulted in the development of two synthetic routes to prepare
syn-like anhydronucleosides modified at the C-1′ position of the 2-α-D-psicofuranosides [104]. Heating
the starting compound psicofuranosyl cytosine 235 [105] with a solution of mercury (II) acetate
followed by iodomercuration of the resulting intermediate afforded the iododinated compound 236,
which was then converted on nucleoside 230 on treatment with potassium tert-butoxide in DMSO
(Scheme 45).
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On the other hand, starting from psicofuranosyl nucleoside 237, acetylation and bromination
gave intermediate 238, which on treatment with methanolic ammonia afforded the cyclonucleoside
239 (Scheme 46).
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Gimisis and collaborators reported the synthesis of a spyronucleoside containing a remarkably
stable orthoamide modification of the C-1′ anomeric position [106]. Starting from uridine 239 [107],
silylation and hydroxymethylation afforded compound 240, which under Suárez conditions afforded,
after deprotection of the silyl groups, derivative 232 (Scheme 47).
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Scheme 47. Reagents and conditions: (i) 1. ButMe2SiCl, imidazole, DMF, r.t., 16 h. 2. LDA, THF,
−70 ◦C, 3 h, HCO2Et, −0 ◦C, 2 h. 3. NaBH4, MeOH, r.t., 30 min, 68%; (ii) PhI(OAc)2, I2, cyclohexane,
hv, 28 ◦C, 5 h; (iii) Bu4NF on SiO2, THF, r.t., 2 h, 90%.
The same researchers also described a synthesis of polycyclic spironucleosides based on the
reaction of l′-C-cyano-pyrimidine nucleosides and organolithium reagents [108,109]. Thus, reaction
of nucleoside 241 with methyllithium afforded, under the appropriate experimental conditions,
spironucleoside 242 (Scheme 48). Then, deprotection of compound 242 by overnight treatment with
ammonium fluoride in refluxing MeOH finally gave the corresponding desilylated nucleoside 233.
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Scheme 49. Reagents and conditions: (i) Amberlyst A15, acetone; (ii) 1. BzCl, Et3N, DMAP, DCM, 0 
°C to r.t. 2. TMSN3, TMSOTf, 4Å MS, CH3CN, 0 °C, 5 min; (iii) 1. AcOH, MeOH, acetone; 2. propargyl 
bromide, CH3CN, 0 °C, 2 h; (iv) toluene, reflux, 24 h; (v) 1. NH3, MeOH; 2. Dowex-H+, MeOH/H2O 8:2, 
50 °C. 
Benzoylation of 244, followed by treatment with azidotrimethylsilane in the presence of 
trimethylsilyl triflate in acetonitrile to afforded compound 245. After acidic hydrolysis of the silyl 
protecting group, O-alkylation of compound with a range of propargyl bromides afforded a series of 
propargyl ether intermediates 246, which underwent intramolecular 1,3-dipolar cycloaddition 
achieved a novel library of protected anomeric spironucleosides 247. Deacylation of 247, followed by 
hydrolysis of the isopropylidene group, yielded finally anomeric spironucleosides 234. 
7. Conclusions 
In summary, this literature review reports on all synthetic approaches to hydantocidin and their 
analogues and also to similar classes of spironucleosides such as diketopiperazines or barbiturates. 
Taking into account the biological relevance of spironucleosides, these derivatives were the synthetic 
target of many researchers since the pioneering work by Mio et al. Most of the reported syntheses of 
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Dell’Isola et al. recently reported the synthesis of bioactive spirocyclic triazolooxasine
nucleosides [110]. The synthetic route started from the isomerization of the D-psicopyranose
derivative 243 [111] into the furanose form 244, promoted by an Amberlyst acid resin in acetone
(Scheme 49).
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Benzoylation of 244, followed by treatment with azidotrimethylsilane in the presence of
trimethylsilyl triflate in acetonitrile to afforded compound 245. After acidic hydrolysis of the silyl
protecting group, O-alkylation of compound with a range of propargyl bromides afforded a series
of propargyl ether intermediates 246, which underwent intramolecular 1,3-dipolar cycloaddition
achieved a novel library of protected anomeric spironucleosides 247. Deacylation of 247, followed by
hydrolysis of the isopropylidene group, yielded finally anomeric spironucleosides 234.
7. Conclusions
In summary, this literature review reports on all synthetic approaches to hydantocidin and their
analogues and also to similar classes of spironucleosides such as diketopiperazines or barbiturates.
Taking into account the biological relevance of spironucleosides, these derivatives were the synthetic
target of many researchers since the pioneering work by Mio et al. Most of the reported syntheses
of spironucleosides have revolved around the use of sugar derivatives as starting materials to
generate the desired stereochemistry of the hydroxyl groups In this regard, the extensive work by
Fleet and co-workers on the preparation of sugar amino acids (SAAs) and their transformation into
spironucleosides provided tremendous advances for the future development of this fascinating class
of biologically active compounds. However, much work remains to be done, as more spironucleoside
analogues are still required for further structure-activities studies. Looking to the future, the
widespread field of application of spironucleosides in medicinal chemistry, and the emergence of
increasingly sophisticated synthetic methodologies, will certainly ensure continued interest in the
development of this class of “synthetic” nucleosides.
Acknowledgments: Financial support from the Xunta de Galicia (Centro singular de investigación de Galicia
accreditation 2016–2019) and the European Union (European Regional Development Fund—ERDF) is greatfully
acknowledged. Gustavo da Silva thanks FCT for his Ph.D. grant (SFRH/BD/103412/2014). Gustavo da Silva
thanks FCT for his Ph.D. grant (SFRH/BD/103412/2014).
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Jordheim, L.P.; Durantel, D.; Zoulim, F.; Dumontet, C. Advances in the development of nucleoside and
nucleotide analogues for cancer and viral diseases. Nat. Rev. Drug Discov. 2013, 12, 447–464. [CrossRef]
[PubMed]
2. De Clercq, E. A 40-year journey in search of selective antiviral chemotherapy. Annu. Rev. Pharmacol. Toxicol.
2011, 51, 1–24. [CrossRef] [PubMed]
3. De Clercq, E. Highlights in the Discovery of Antiviral Drugs: A Personal Retrospective. J. Med. Chem. 2010,
53, 1438–1450. [CrossRef] [PubMed]
4. Mehellou, Y.; De Clercq, E. Twenty-six years of anti-HIV drug discovery: Where do we stand and where do
we go? J. Med. Chem. 2010, 53, 521–538. [CrossRef] [PubMed]
5. De Clercq, E. The history of antiretrovirals: Key discoveries over the past 25 years. Rev. Med. Virol. 2009, 19,
287–299. [CrossRef] [PubMed]
6. Bonate, P.L.; Arthaud, L.; Cantrell, W.R., Jr.; Stephenson, K.; Secrist, J.A., III; Weitman, S. Discovery and
development of clofarabine: A nucleoside analogue for treating cancer. Nat. Rev. Drug Discov. 2006, 5,
855–863. [CrossRef] [PubMed]
7. Elgemeie, G. Thioguanine, mercaptopurine: Their analogs and nucleosides as antimetabolites. Curr. Pharm. Des.
2003, 9, 2627–2642. [CrossRef] [PubMed]
8. Miura, S.; Izuta, S. DNA polymerases as targets of anticancer nucleosides. Curr. Drug Targets 2004, 5, 191–195.
[CrossRef] [PubMed]
9. Parker, W.; Secrist, J.; Waud, W. Purine nucleoside antimetabolites in development for the treatment of cancer.
Curr. Opin. Investig. Drugs 2004, 5, 592–596. [PubMed]
10. Sharma, P.; Nurpeisov, V.; Hernandez-Santiago, B.; Beltran, T.; Schinazi, R. Nucleoside inhibitors of human
immunodeficiency virus type 1 reverse transcriptase. Curr. Top. Med. Chem. 2004, 4, 895–919. [CrossRef]
[PubMed]
Molecules 2017, 22, 2028 31 of 35
11. Otto, M. New nucleoside reverse transcriptase inhibitors for the treatment of HIV infections. Curr. Opin.
Pharmacol. 2004, 4, 431–436. [CrossRef] [PubMed]
12. Watts, J.K. Locked nucleic acid: Tighter is different. Chem. Commun. 2013, 49, 5618–5620. [CrossRef] [PubMed]
13. Marquez, V.E.; Ezzitouni, A.; Russ, P.; Siddiqui, M.A.; Ford, H.; Feldman, R.J.; Mitsuya, H.; George, C.;
Barchi, J.J. HIV-1 Reverse transcriptase can discriminate between two conformationally locked carbocyclic
AZT triphosphate analogues. J. Am. Chem. Soc. 1998, 120, 2780–2789. [CrossRef]
14. Herdewijn, P. Targeting RNA with conformationally restricted oligonucleotides. Liebigs Ann. Chem. 1996,
1996, 1337–1348. [CrossRef]
15. Kool, E.T. Preorganization of DNA: Design principles for improving nucleic acid recognition by synthetic
oligonucleotides. Chem. Rev. 1997, 97, 1473–1488. [CrossRef] [PubMed]
16. Wengel, J. Synthesis of 3′-C- and 4′-C-branched oligodeoxynucleotides and the development of locked
nucleic acid (LNA). Acc. Chem. Res. 1999, 32, 301–310. [CrossRef]
17. Soengas, R.G.; Sandrina, S. Spirocyclic nucleosides in medicinal chemistry: An overview. Mini Rev. Med. Chem.
2012, 12, 1485–1496. [CrossRef] [PubMed]
18. Haneishi, T.; Nakajima, M.; Torikata, A.; Okazaki, T.; Tohjigamori, M.; Kawakubo, K. Process for the
Production of an Imidazoledione Compound by a Strain of Streptomyces hygroscopicus. U.S. Patent 5,064,760,
12 November 1991.
19. Haneishi, T.; Nakajima, M.; Torikata, A.; Okazaki, T.; Tohjigamori, M.; Kawakubo, K. Imidazoledione
Compounds Useful as Herbicides. U.S. Patent 4,952,234, 28 August 1990.
20. Pachlatko, J.P.; Zaehner, H.P. New Streptomyces hygroscopicus TU-2474 for Production of the Herbicide
Hydantocidin and the Bactericide Homomycin. D.E. Patent 4,129,616, 03 December 1992.
21. Mitsubishi Kasei Corp. Synthesis of Spiroacetal Nucleosides. J.P. Patent 04,222,589, 1990.
22. Nakajima, M.; Itoi, K.; Takamatsu, Y.; Kinoshita, T.; Okazaki, T.; Kawakubo, K.; Shindo, M.; Honma, T.;
Tohjigamori, M.; Haneishi, T. Hydantocidin: A new compound with herbicidal activity from Streptomyces
hygroscopicus. J. Antibiot. 1991, 44, 293–300. [CrossRef] [PubMed]
23. Heim, D.R.; Cseke, C.; Gerwick, B.C.; Murdoch, M.G.; Green, S.B. Hydantocidin: a possible proherbicide
inhibiting purine biosynthesis at the site of adenylosuccinate synthetase. Pestic. Biochem. Physiol. 1995, 53,
138–145. [CrossRef]
24. Smith, J.L. Enzymes of nucleotide synthesis. Curr. Opin. Struct. Biol. 1995, 5, 752–757. [CrossRef]
25. Gregoriou, M.; Noble, M.E.M.; Watson, K.A.; Garman, E.F.; Krülle, T.M.; de la Fuente, C.; Fleet, G.W.J.;
Oikonomakos, N.G.; Johnson, L.N. The structure of a glycogen phosphorylase glucopyranose spirohydantoin
complex at 1.8 A resolution and 100 K: The role of the water structure and its contribution to binding.
Protein Sci. 1998, 7, 915–927. [CrossRef] [PubMed]
26. Barford, D.; Johnson, L.N. The allosteric transition of glycogen phosphorylase. Nature 1989, 340, 609–616.
[CrossRef] [PubMed]
27. Livanova, N.B.; Kornilaev, B.A. Structure, regulation, and denaturation of rabbit muscle glycogen
phosphorylase b. Biochemistry 1996, 61, 1432–1442.
28. Johnson, L.N.; O’Reilly, M. Control by phosphorylation. Curr. Opin. Struct. Biol. 1996, 6, 762–769. [CrossRef]
29. Ortmeyer, H.K.; Bodkin, N.L.; Hansen, B.C. Insulin regulates liver glycogen synthase and glycogen
phosphorylase activity reciprocally in rhesus monkeys. Am. J. Physiol. 1997, 272, E133–E138. [PubMed]
30. Martin, J.L.; Veluraja, K.; Ross, K.; Johnson, L.N.; Fleet, G.W.J.; Ramsden, N.G.; Bruce, I.; Orchard, M.G.;
Oikonomakos, N.G.; Papageorgiou, A.C.; et al. Glucose analogue inhibitors of glycogen phosphorylase: The
design of potential drugs for diabetes. Biochemistry 1991, 30, 10101–10116. [CrossRef] [PubMed]
31. Watson, K.A.; Mitchell, E.P.; Johnson, L.N.; Son, J.C.; Bichard, C.J.F.; Orchard, M.G.; Fleet, G.W.J.;
Oikonomakos, N.G.; Leonidas, D.D.; Kontou, M.; et al. Design of inhibitors of glycogen phosphorylase:
A study of .alpha.- and .beta.-C-glucosides and 1-thio-.beta.-D-glucose compounds. Biochemistry 1994, 33,
5745–5758. [CrossRef] [PubMed]
32. Board, M.; Bollen, M.; Stalmans, W.; Kim, Y.; Fleet, G.W.J.; Johnson, L.N. Effects of C-1-substituted glucose
analogue on the activation states of glycogen synthase and glycogen phosphorylase in rat hepatocytes.
Biochem. J. 1995, 311, 845–852. [CrossRef]
33. Martin, J.L.; Johnson, L.N.; Withers, S.G. Comparison of the binding of glucose and glucose 1-phosphate
derivatives to T-state glycogen phosphorylase b. Biochemistry 1990, 29, 10745–10757. [CrossRef] [PubMed]
Molecules 2017, 22, 2028 32 of 35
34. Osei, K. Diabetes, Clinical Science in Practice; Leslie, R.D.G., Robbins, D.C., Eds.; Cambridge University:
Cambridge, UK, 1995; Chapter 12; ISBN 0521450292.
35. DeFronzo, R.A. The triumvirate: Cell, muscle, liver: A collusion responsible for NIDDM. Diabetes 1988, 37,
667–687. [CrossRef] [PubMed]
36. Mio, S.; Ichinose, R.; Goto, K.; Sugai, S. Synthetic studies on (+)-hydantoicin: A total synthesis of
(+)-hydantoicin, a new herbicidal metabolite from microorganism. Tetrahedron 1991, 47, 2111–2120. [CrossRef]
37. Mio, S.; Kumagawa, Y.; Sugai, S. Synthetic studies on (+)-hydantocidin (3): A new synthetic method for
construction of the spiro-hydantoin ring at the anomeric position of D-ribofuranose. Tetrahedron 1991, 47,
2133–2144. [CrossRef]
38. Prisbe, E.J.; Smejkal, J.; Verheyder, J.P.H.; Moffat, L.J.G. Halo sugar nucleosides. V. Synthesis of angustmycin
A and some base analogues. J. Org. Chem. 1976, 41, 1836–1846. [CrossRef] [PubMed]
39. Chemla, P. Stereoselective Synthesis of (+)-Hydantocidin. Tetrahedron Lett. 1993, 34, 7391–7394. [CrossRef]
40. Shiozaki, M. Syntheses of hydantocidin and C-2-thioxohydantocidin. Carbohydr. Res. 2002, 337, 2077–2088.
[CrossRef]
41. Mio, S.; Shiraishi, M.; Sugai, S. Synthetic studies on (+)-hydantocidin (2): Aldol addition approaches towards
the stereoisomers of (+)-hydantocidin. Tetrahedron 1991, 47, 2121–2132. [CrossRef]
42. Mio, S.; Ueda, M.; Hamura, M.; Kitakawa, J.; Sugai, S. Synthetic studies on (+)-hydantocidin (4): Synthesis of
stereoisomers of (+)-hydantocidin. Tetrahedron 1991, 47, 2145–2154. [CrossRef]
43. Fairbanks, A.J.; Fleet, G.W.J. Synthesis of 5-epihydantocidin from D-Ribose. Tetrahedron 1995, 51, 3881–3894.
[CrossRef]
44. Hsia, K.Y.; Ward, P.; Lamont, R.B.; Lilley, P.M.; De, Q.; Watkin, D.J.; Fleet, G.W.J. Formation of highly
substituted cyclopentanes from radical and anionic Michael cyclisations of α-iodo-γ- and -δ-lactones.
Tetrahedron Lett. 1994, 35, 4823–4826. [CrossRef]
45. Mio, S.; Sane, H.; Shindou, M.; Honma, T.; Sugai, S. Synthesis and herbicidal activity of deoxy derivatives of
(+)-hydantocidin. Agric. Biol. Chem. 1991, 55, 1105–1109.
46. Burton, J.W.; Son, J.C.; Fairbanks, A.J.; Choi, S.S.; Taylor, H.; Watkin, D.J.; Winchester, B.G.; Fleet, G.W.J.
Anomeric spirohydantoins of mannofuranose: Approaches to novel anomeric amino acids by oxidative ring
contraction. Tetrahedron Lett. 1993, 34, 6119–6122. [CrossRef]
47. Brandstetter, T.W.; Kim, Y.; Son, J.C.; Taylor, H.M.; Lilley, P.M.D.Q.; Watkin, D.J.; Johnson, L.N.;
Oikonomakos, N.G.; Fleet, G.W.J. Spirohydantoins of glucofuranose: Analogues of hydantocidin.
Tetrahedron Lett. 1995, 36, 2149–2152. [CrossRef]
48. Blériot, Y.; Simone, M.I.; Wormald, M.R.; Dwek, R.A.; Watkin, D.J.; Fleet, G.W.J. Sugar amino acids at
the anomeric position of carbohydrates: Synthesis of spirocyclic amino acids of 6-deoxy-L-lyxofuranose.
Tetrahedron Asymm. 2006, 17, 2276–2286. [CrossRef]
49. Szewczyk, K. Aldono-1,5-lactones: Preparation, nucleophilic substitution and deoxygenation reactions.
Pol. J. Chem. 2000, 74, 1275–1282.
50. Bichard, C.J.F.; Mitchell, E.P.; Wormald, M.R.; Watson, K.A.; Johnson, L.N.; Zographos, S.E.; Koutra, D.D.;
Oikonomakos, N.G.; Fleet, G.W.J. Potent inhibition of glycogen phosphorylase by a spirohydantoin of
glucopyranose: First pyranose analogues of hydantocidin. Tetrahedron Lett. 1995, 36, 2145–2148. [CrossRef]
51. Bichard, C.J.F.; Wheatley, J.R.; Fleet, G.W.J. Acetonides of heptonolactones: Kiliani ascension of
3-O-benzyl-D-glucose and 3-O-benzyl-D-allose. Tetrahedron Asymm. 1994, 5, 431–440. [CrossRef]
52. Fuente, C.; Krülle, T.M.; Watson, K.A.; Gregoriou, M.; Johnson, L.N.; Zographos, S.E.; Oikonomakos, N.G.;
Fleet, G.W.J. Glucopyranose analogues of spirohydantoins: Specific inhibitors of glycogen phosphorylase.
Synlett 1997, 485–487. [CrossRef]
53. Wheatley, J.R.; Beacham, A.R.; Lilley, P.M.D.Q.; Watkin, D.J.; Fleet, G.W.J. Ketals of L-rhamnoheptonolactones:
Potential mimics of L-rhamnose. Tetrahedron Asymm. 1994, 5, 2523–2534. [CrossRef]
54. Estevez, J.C.; Smith, M.D.; Lane, A.L.; Crook, S.; Watkin, D.J.; Besra, G.S.; Brennan, P.J.; Nash, R.J.; Fleet, G.W.J.
Mimics of L-rhamnose: Analogues of rhamnopyranose containing a constituent amino acid at the anomeric
position. A rhamnopyranose analogue of hydantocidin. Tetrahedron Asymm. 1996, 7, 391–394. [CrossRef]
55. Brandstetter, T.W.; Wormald, M.R.; Dwek, R.A.; Butters, T.D.; Platt, F.M.; Tsitsanou, K.E.; Zographos, S.E.;
Oikonomakos, N.G.; Fleet, G.W.J. A galactopyranose analogue of hydantocidin. Tetrahedron Asymm. 1996, 7,
157–170. [CrossRef]
Molecules 2017, 22, 2028 33 of 35
56. Köll, P.; Frötsch, A. Ein neuer effizienter weg zur darstellung von glycopyranosylcyaniden
(2,6-anhydroaldononitrilen) ohne nachbargruppenbeteiligung. Reduktion von 2,6-anhydro-1-desoxy-1-
nitroalditolen mit phosphortrichlorid. Carbohydr. Res. 1987, 171, 301–315. [CrossRef]
57. Elliott, R.P.; Hui, A.; Fairbanks, A.J.; Nash, R.J.; Winchester, B.G.; Way, G.; Smith, C.; Lamont, B.; Storer, R.;
Fleet, G.W.J. Highly substituted cis-β-cyclopentane amino acids: An approach to the synthesis of trehazolin
analogues. Tetrahedron Lett. 1993, 34, 7949–7952. [CrossRef]
58. Fairbanks, A.J.; Elliott, R.P.; Smith, C.; Hui, A.; Way, G.; Storer, R.; Taylor, H.; Watkin, D.J.; Winchester, B.G.;
Fleet, G.W.J. Synthesis of cyclopentane spirohydantoins by aldol cyclisations: An approach to highly
substituted α-cyclopentane amino acids. Tetrahedron Lett. 1993, 34, 7953–7956. [CrossRef]
59. Skead, B.M.; Fleet, G.W.J.; Saunders, J.R.B.; Lament, R.B. Cyclic sulphates of δ-lactones in the synthesis of
tetrahydrofurans, tetrahydropyrans and cyclohexanes. Tetrahedron Lett. 1993, 34, 6115–6118. [CrossRef]
60. Fairbanks, A.J.; Hui, A.; Skead, B.M.; Lilley, P.M.; Lamont, R.B.; Storer, R.; Saunders, J.; Watkin, D.J.;
Fleet, G.W.J. Polyhydroxylated cyclohexane and cyclopentane α-amino acids from cyclisations of
an azidolactone. Tetrahedron Lett. 1994, 35, 8891–8894. [CrossRef]
61. Sano, H.; Sugai, S. Synthesis of (±)-carbocyclic analogue of spirohydantoin nucleoside. Tetrahedron 1995, 51,
4635–4646. [CrossRef]
62. Sano, H.; Sugai, S. Synthesis of an optically active carbocyclic derivative of (+)-hydantocidin. Tetrahedron
Asymm. 1995, 6, 1143–1150. [CrossRef]
63. Pham, T.Q.; Pyne, S.G.; Skelton, B.W.; White, A.H. Synthesis of carbocyclic hydantocidins via regioselective
and diastereoselective phosphinecatalyzed [3 + 2]-cycloadditions to 5-methylenehydantoins. J. Org. Chem.
2005, 70, 6369–6377. [CrossRef] [PubMed]
64. Hanessian, S.; Sancéau, J.-Y.; Chemla, P. Synthesis of surrogate structures related to the herbicidal agent
hydantocidin. Tetrahedron 1995, 51, 6669–6678. [CrossRef]
65. Sano, H.; Mio, S.; Kitagawa, J.; Shindou, M.; Honma, T.; Sugai, S. Synthesis of spirothiohydantoin analogues
of hydantocidin. Tetrahedron 1995, 51, 12561–12572. [CrossRef]
66. Lamberth, C.; Blarer, S. Concise approach to 1-thia-hydantocidin. Synth. Commun. 1996, 26, 75–81. [CrossRef]
67. Utimoto, K.; Wakabayashi, Y.; Horiie, T.; Inoue, M.; Shishiyama, Y.; Obayashi, M.; Nozaki, H.
Cyanotrimethylsilane as a versatile reagent for introducing cyanide functionality. Tetrahedron 1983, 39,
967–973. [CrossRef]
68. Osz, E.; Somsák, L.; Sziládgy, L.; Dinya, Z. A Straightforward route to hydantocidin analogues with pyranose
ring structure. Tetrahedron 1997, 53, 5813–5824. [CrossRef]
69. Osz, E.; Somsák, L.; Sziládgy, L.; Kováks, L.; Docsa, T.; Tóth, B.; Gergely, P. Efficient inhibition of muscle and
liver glycogen phosphorylases by a new glucopyranosylidene-spiro-thiohydantoin. Bioorg. Med. Chem. Lett.
1999, 9, 1385–1390. [CrossRef]
70. Somsák, L.; Nagy, V.; Docsa, T.; Tóth, B.; Gergely, P. Gram-scale synthesis of a glucopyranosylidene-
spirothiohydantoin and its effect on hepatic glycogen metabolism studied in vitro and in vivo. Tetrahedron
Asymm. 2000, 11, 405–408. [CrossRef]
71. Somsák, L.; Nagy, V. A new, scalable preparation of a glucopyranosylidene-spiro-thiohydantoin: One of the
best inhibitors of glycogen phosphorylases. Tetrahedron Asymm. 2000, 11, 1719–1727. [CrossRef]
72. Somsák, L.; Batta, G.; Farkas, I. Preparation of acetylated C-(1-bromo-D-glycosyl) heterocycles and
1-bromo-D-glycosyl cyanides. Carbohydr. Res. 1983, 124, 43–51. [CrossRef]
73. Ghoneim, A.A. Synthesis of some nucleosides derivatives from L-rhamnose with expected biological activity.
Chem. Cent. J. 2011, 5, 7–11. [CrossRef] [PubMed]
74. Lockhoff, O. Acetale als anomere zentren von kohlenhydraten (Hal/O- und O/O-Acetale). In Methoden der
Organischen Chemie (Houben-Weyl); Hagemann, H., Klamann, D., Eds.; Thieme: Stuttgart, Germany, 1992;
Volume E14a/3, p. 708. ISBN 1588900223.
75. Adamczeski, M.; Reed, A.R.; Crews, P. New and known diketopiperazines from the caribbean sponge, calyx
cf. podatypa. J. Nat. Prod. 1995, 58, 201–208. [CrossRef] [PubMed]
76. Funabashi, Y.; Horiguchi, T.; Iinuma, S.; Tanida, S.; Hamda, S. TAN-1496 A, C and E, diketopiperazine
antibiotics with inhibitory activity against mammalian DNA topoisomerase I. J. Antibiot. 1994, 47, 1202–1218.
[CrossRef] [PubMed]
77. Barrow, C.I.; Musza, L.L.; Cooper, R. Structure-activity studies of the natural product substance P antagonist
win 64821. Bioorg. Med. Chem. Lett. 1995, 5, 377–380. [CrossRef]
Molecules 2017, 22, 2028 34 of 35
78. Estevez, J.C.; Ardron, H.; Wormald, M.R.; Brown, D.; Fleet, G.W.J. Spirocyclic peptides at the anomeric
position of mannofuranose. Tetrahedron Lett. 1994, 35, 8889–8890. [CrossRef]
79. Estevez, J.C.; Burton, J.W.; Estevez, R.J.; Ardron, H.; Wormald, M.R.; Dwek, R.A.; Brown, D.; Fleet, G.W.J.
Spirodiketopiperazines of mannofuranose: Carbopeptoid α-amino acid esters at the anomeric position of
mannofuranose. Tetrahedron Asymm. 1998, 9, 2137–2154. [CrossRef]
80. Estévez, J.C.; Estévez, R.J.; Ardron, H.; Wormald, M.R.; Brown, D.; Fleet, G.W.J. Tri- and tetra-peptides
incorporating an α-amino acid at the anomeric position of mannofuranose. Tetrahedron Lett. 1994, 35,
8885–8888. [CrossRef]
81. Long, D.D.; Tennant-Eyles, R.J.; Estevez, J.C.; Wormald, M.R.; Dwek, R.A.; Smith, M.D.; Fleet, G.W.J.
Carbopeptoids: Peptides and diketopiperazines incorporating the anomeric centre of mannopyranose.
J. Chem. Soc. Perkin Trans. 1 2001, 8, 807–813. [CrossRef]
82. Krülle, T.M.; Watson, K.A.; Gregoriou, M.; Johnson, L.N.; Crook, S.; Watkin, D.J.; Griffiths, R.C.;
Nash, R.J.; Tsitsanou, K.E.; Zographos, S.E.; et al. Specific inhibition of glycogen phosphorylase by
a spirodiketopiperazine at the anomeric position of glucopyranose. Tetrahedron Lett. 1995, 36, 8291–8294.
[CrossRef]
83. Estevez, J.C.; Saunders, J.; Besra, G.S.; Brennan, P.J.; Nash, R.J.; Fleet, G.W.J. Mimics of L-rhamnose: Synthesis
of C-glycosides of L-rhamnofuranose and an α-azidoester as divergent intermediates for combinatorial
generation of rhamnofuranose libraries. Tetrahedron Asymm. 1996, 7, 383–386. [CrossRef]
84. Paquette, L.A.; Brand, S.; Behrens, C. An enantioselective ring expansion route leading to furanose and
pyranose nucleosides featuring spirodiketopiperazines at the anomeric position. J. Org. Chem. 1999, 64,
2010–2025. [CrossRef] [PubMed]
85. Kyogoku, Y.; Lord, R.C.; Rich, A. Specific hydrogen bonding of barbiturates to adenine derivatives. Nature
1968, 218, 69–72. [CrossRef] [PubMed]
86. Ito, T.; Suzuki, T.; Wellman, S.E.; Ho, I.K. Pharmacology of barbiturate tolerance/dependence: GABAA
receptors and molecular aspects. Life Sci. 1996, 59, 169–195. [CrossRef]
87. Renard, A.; Lhomme, J.; Kotera, M. Synthesis and properties of Spiro nucleosides containing the barbituric
acid moiety. J. Org. Chem. 2002, 67, 1302–1307. [CrossRef] [PubMed]
88. Sano, H.; Mio, S.; Kitakawa, J.; Sugai, S. Stereocontrolled synthesis of spirodihydrouracil nucleoside.
Tetrahedron Asymm. 1994, 5, 2233–2240. [CrossRef]
89. Sano, H.; Mio, S.; Hamura, M.; Kitagawa, J.; Shindou, M.; Honma, T.; Sugai, S. Synthesis and herbicidal
activity of hydantocidin analogues: Modification of the carbonyl groups in spirohydantoin. Biosci. Biotechnol.
Biochem. 1995, 59, 2247–2250. [CrossRef]
90. Fuentes, J.; Salameh, B.A.B.; Pradera, M.A.; Fernandez de Cordoba, F.J.; Gasch, C. Stereocontrolled synthesis
of thiohydantoin spiro-nucleosides from sugar spiroacetals. Tetrahedron 2006, 62, 97–111. [CrossRef]
91. Gasch, C.; Pradera, M.A.; Salameh, B.A.B.; Molina, J.L.; Fuentes, J. Isothiocyanato derivatives of sugars in the
stereoselective synthesis of spironucleosides and spiro-C-glycosides. Tetrahedron Asymm. 2001, 12, 1267–1277.
[CrossRef]
92. Vangala, M.; Shinde, G.P. Synthesis of D-fructose-derived spirocyclic 2-substituted-2-oxazoline ribosides.
Beilstein J. Org. Chem. 2015, 11, 2289–2296. [CrossRef] [PubMed]
93. Kraft, J.; Golkowski, M.; Ziegler, T. Spiro-fused carbohydrate oxazoline ligands: Synthesis and application
as enantio-discrimination agents in asymmetric allylic alkylation. Beilstein J. Org. Chem. 2016, 12, 166–171.
[CrossRef] [PubMed]
94. Soengas, R.G. A straightforward route to novel α,α-disubstituted tetrahydrofuran β-amino acids and
spirodiketopiperazines from sugar lactones. Synlett 2010, 2549–2552. [CrossRef]
95. Maza, S.; López, O.; Martos, S.; Maya, I.; Fernández-Bolaños, J.G. Synthesis of the first selenium-containing
acyclic nucleosides and anomeric spironucleosides from carbohydrate precursors. Eur. J. Org. Chem. 2009,
5239–5246. [CrossRef]
96. Taillefumier, C.; Thielges, S.; Chapleur, Y. Anomeric spiro-annelated 1,4-diazepine 2,5-diones from furano
exo-glycals: Towards a new class of spiro-nucleosides. Tetrahedron 2004, 60, 2213–2224. [CrossRef]
97. Lakhrissi, M.; Chapleur, Y. Wittig Olefination of Lactones. Angew. Chem. Int. Ed. Engl. 1996, 35, 750–752.
[CrossRef]
98. Nakahara, T.; Okamoto, N.; Suzuki, K.; Kanie, O. Synthetic studies towards a new scaffold,
spirobicycloimidazoline. Carbohydr. Res. 2008, 343, 1624–1635. [CrossRef] [PubMed]
Molecules 2017, 22, 2028 35 of 35
99. Martin, A.; Perez-Martin, I.; Suarez, E. Intramolecular hydrogen abstraction promoted by amidyl radicals.
Evidence for electronic factors in the nucleophilic cyclization of ambident amides to oxocarbenium ions.
Org. Lett. 2005, 7, 2027–2030. [CrossRef] [PubMed]
100. Pal, A.P.J.; Kadigachalam, P.; Mallick, A.; Doddi, V.R.; Vankar, Y.D. Synthesis of sugar-derived spiroaminals
via lactamization and metathesis reactions. Org. Biomol. Chem. 2011, 9, 809–819.
101. Pal, A.P.J.; Vankar, Y.D. Azidation of anomeric nitro sugars: Application in the synthesis of spiroaminals as
glycosidase inhibitors. Tetrahedron Lett. 2010, 51, 2519–2524.
102. Martin, A.; Perez-Martin, I.; Suarez, E. Synthesis of oxa-aza spirobicycles by intramolecular hydrogen atom
transfer promoted by N-radicals in carbohydrate systems. Tetrahedron 2009, 65, 6147–6155. [CrossRef]
103. Benltifa, M.; De Kiss, M.; Garcia-Moreno, M.I.; Mellet, C.O.; Gueyrard, D.; Wadouachi, A. Regioselective
synthesis and biological evaluation of spiro-sulfamidate glycosides from exo-glycals. Tetrahedron Asymm.
2009, 20, 1817–1823. [CrossRef]
104. Zavgorodny, S.G. A novel type of anhydronucleosides to model syn-conformers of natural nucleosides.
Tetrahedron Lett. 1981, 22, 3003–3006. [CrossRef]
105. Farkaii, J.; Sorm, F. Nucleic acid components and their analogues. XXX. The synthesis of psicofuranine.
Collect. Czechoslov. Chem. Commun. 1963, 28, 882–886. [CrossRef]
106. Gimisis, T.; Castellari, C.; Chatgilialoglu, C. A new class of anomeric spironucleosides. Chem. Commun. 1997,
0, 2089–2090. [CrossRef]
107. Groziak, M.P.; Koohang, A.; Stevens, W.C.; Robinson, P.D. A new class of nucleosides possessing unusual
physical properties: Syntheses, hydration, and structural equilibria of 1-(.beta.-D-glycofuranosyl)uracil-
6-carboxaldehydes. J. Org. Chem. 1993, 58, 4054–4060. [CrossRef]
108. Chatgilialoglu, C.; Ferreri, C.; Gimisis, T. Anionically induced formation of anomeric spironucleosides from
l′-C-Cyano-2′-deoxyuridine. Tetrahedron Lett. 1999, 40, 2837–2840. [CrossRef]
109. Chatgilialoglu, C.; Ferreri, C.; Gimisis, T.; Roberti, M.; Balzarini, J.; De Clercq, E. Synthesis and biological
evaluation of novel branched and spironucleoside analogues. Nucleosides Nucleotides Nucleic Acids 2004, 23,
1565–1581. [CrossRef] [PubMed]
110. Dell’Isola, A.; McLachlan, M.M.W.; Neuman, B.W.; Al-Mullah, H.M.N.; Binks, A.W.D.; Elvidge, W.;
Shankland, K.; Cobb, A.J.A. Synthesis and antiviral properties of spirocyclic [1,2,3]-triazolooxazine
nucleosides. Chem. Eur. J. 2014, 20, 11685–11689. [CrossRef] [PubMed]
111. Perali, R.S.; Mandava, S.; Bandi, R. A convenient synthesis of L-ribose from D-fructose. Tetrahedron 2011, 67,
4031–4035. [CrossRef]
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
